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Summary 
 
Cys-loop receptors are ligand-gated ion channels that are involved in fast 
synaptic neurotransmission in the central and peripheral nervous system. The 
Cys-loop receptor RDL (‘resistant to dieldrin’) is a GABA-gated chloride 
channel from Drosophila melanogaster and is a major target site for 
insecticides. The aim of this dissertation was to characterise RDL receptors 
with particular focus on the agonist binding site. 
To assess the potency of a range of GABA analogues on RDL receptors, I 
expressed receptors in Xenopus oocytes and used voltage-clamp 
electrophysiology to detect receptor responses. I carried out computational 
modelling of these analogues to determine the dipole separation distances and 
atomic charges. Computational calculations and functional experiments 
revealed that agonists require a charged ammonium and an anionic centre, with 
the most potent agonists having a dipole separation distance of ~5 Å. I made a 
homology model of the extracellular domain of RDL and docked the active 
analogues into the putative binding site. I then conducted mutagenesis studies 
to test the accuracy of this model. Functional data from mutagenesis studies 
broadly support the location of GABA within this model. This model may be 
useful for further structure−activity studies and rational drug design.  
Natural compounds from the traditional Chinese medicine ‘Ginkgo biloba’ 
(ginkgolide A, ginkgolide B and bilobalide) have potent insecticidal properties 
and are similar in structure to picrotoxin. I tested the effect of these compounds 
on RDL receptor function using voltage-clamp electrophysiology. All 
compounds were found to inhibit RDL receptor function. I probed the binding 
site of these compounds using site-directed mutagenesis and electrophysiology. 
Mutations to the 2'A and 6'T channel-lining (M2) residues greatly reduced the 
potency of these compounds. I then made a homology model of the 
transmembrane domain of RDL and docked these compounds into the channel. 
Compounds docked into the channel pore close to the 2' and 6' channel-lining 
residues and H-bonding interactions were detected at these locations. 
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Ginkgolides are therefore antagonists of RDL receptors, binding in the channel 
close to the 2' and 6' residues and this may be the mechanism underlying their 
potent insecticidal properties. 
The 5-HT3 receptor is a member of the Cys-loop receptor family and shows 
homology to RDL receptors. To explore different techniques for studying Cys-
loop receptor function I assessed the functionality of two brain derived 
transcripts of the 5-HT3B subunit (Br1 and Br2) using single-channel 
electrophysiology and a fluorometric assay. Receptors containing Br1 were 
found to have a conductance identical to the 5-HT3B subunit whilst Br2 
receptors were found not to be expressed. This finding has implications for 5-
HT3 brain signalling, in which Br1 may play an important role. 
In conclusion, work here has described how agonists bind to and activate RDL 
GABA receptors and I have identified a candidate mechanism for the potent 
insecticidal properties of Ginkgo biloba extracts. I have also confirmed that 5-
HT3 receptor brain transcript Br1 forms functional channels with similar 
properties to the 5-HT3B subunit. 
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Introduction 
 
 
1.1 Neurotransmission 
 
Neurons convey information to one another through the use of both electrical 
and chemical signals. Neurons pass an electrical signal down the length of their 
axons by means of voltage-gated ion channels which open in response to local 
changes in membrane potential. The passing of this signal along the axon is 
known as an action potential. Action potentials can trigger the release of 
vesicles containing neurotransmitters from the pre-synaptic membrane. 
Neurotransmitters propagate the signal that was generated as an electrical 
action potential as a chemical signal by binding to their post-synaptic receptors 
and eliciting the opening of ion channels. These ligand-gated ion channels can 
contribute to either excitatory post-synaptic potentials (EPSPs) or inhibitory 
post-synaptic potentials (IPSPs). Ligand-gated ion channels allow the 
conversion of the chemical signal transmitted by neurotransmitters to a change 
of post-synaptic potential on a millisecond timescale, thus facilitating fast 
synaptic transmission. 
 
1.2 The ligand-gated ion channel superfamily 
 
The “ligand-gated ion channel” (LGIC) family of membrane proteins refers to 
a group of structurally related receptors that consist of a ligand-binding 
domain, and an intrinsic ion-channel domain. Fast synaptic neurotransmission 
is mediated by these LGICs, which open in response to the binding of 
neurotransmitter molecules. The three major classes of LGICs are ATP gated 
ion channels (P2X receptors), the family of glutamate gated-ion channels 
(NMDA, AMPA and kainate receptors) and the Cys-loop family of LGICs 
(Hogg et al., 2005).  Intracellular second messenger activated receptors such 
as NAADP (nicotinic acid adenine dinucleotide phosphate), ryanodine and 
IP3 activated receptors - which are involved in the release of intracellular 
calcium stores - are also ligand-gated ion channels in this superfamily (Taylor 
and Laude, 2002). These types of LGICs are distinct from – and should not be 
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confused with – other ion channels which can be activated by distinct ligand-
activated receptors; for example, the GABAB receptors are G-protein coupled 
receptors which can (indirectly, through a small G-protein) activate potassium 
channels (See Ong and Kerr (2000) for a review). Whilst GABAB and GABAA 
receptors are the two major classes of vertebrate GABA receptors, from here 
onwards we will focus on the Cys-loop receptor family of LGICs, with special 
focus on GABAA receptors, which are pentameric intrinsic ion channel 
receptors. 
 
1.3 Cys-loop receptors 
 
Members of the Cys-loop receptor family share amino acid sequence 
homology. Receptors include the nicotinic acetylcholine receptor (nAChR), the 
γ-amino-butyric-acid type A receptor (GABAAR), the glycine receptor (GlyR) 
the serotonin type 3 receptor (5-HT3R) (Barnard, 1992) and the more recently 
discovered zinc-activated channel (ZAC) (Davies et al., 2003; Hogg et al., 
2005). Cys-loop receptor subunits are approximately 420-600 amino acids in 
size with a mass of 50-70 kDa and different members of the family share 
approximately 30% sequence identity. 
 
Cys-loop receptors can be distinguished by their different sensitivity to agonists 
and their intrinsic ionic selectivity. Both nAChR and 5-HT3 receptors select 
cations, which usually results in EPSPs favouring the generation of an action 
potential in the post-synaptic neuron. The GABAAR and GlyR usually mediate 
post-synaptic inhibition of neurotransmission by generating IPSPs via the 
influx of anions into the post-synaptic neuron. The direction of ion flux through 
channels is dependent on the local electrochemical gradient and there are cases 
where anion channels can in fact be excitatory; in the developing neocortex for 
example, the activation of GABAA channels results in chloride efflux, leading 
to the generation of EPSPs (Staley et al., 1995). For the most part, however, 
GABAA receptor activation results in a hyperpolarisation of the post-synaptic 
neuron which disfavours the opening of voltage-gated ion channels and the 
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generation of an action potential. Glycine receptors dominate motor neuron 
inhibition, whilst GABA is the major inhibitory neurotransmitter in the brain.  
Cys-loop receptors have also been identified in insects. For example, recent 
studies in the fruit fly (Drosophila melanogaster) (Bocquet et al., 2009) honey 
bee (Apis mellifera) and red flour beetle (Tribolium castaneum) (Jones and 
Sattelle, 2007; 2006: Littleton and Ganetzky, 2000) have identified Cys-loop 
receptors, including nAChRs (Sattelle et al., 2005), anion and cation GABA-
gated channels (Buckingham et al., 2005) and glutamate- and histamine-gated 
anion channels (Gisselmann et al., 2002; Stein et al., 2003; Zheng et al., 2002).  
Cys-loop receptors have also been identified in other species of animal; in the 
small crab (Cancer borealis), GABA- and glutamate-gated anion channels have 
been identified (Duan and Cooke, 2000; Swensen et al., 2000). Additionally, 
the nematode Caenorhabditis elegans possesses a wide range of Cys-loop 
receptors, with 90 ligand-gated ion channel genes identified to date (Bargmann, 
1998). These include the receptors EXP-1, a GABA-gated cation channel that 
mediates enteric muscle contraction (Beg and Jorgensen, 2003) and MOD-1, a 
serotonin-gated anion channel (Ranganathan et al., 2000). A review of the Cys-
loop receptors of Caenorhabditis elegans has been published recently by Jones 
and Sattelle (2008). More recently, Cys-loop receptor orthologues have been 
identified in the bacteria Gloebacter violaceus and Erwinia chrysanthemi, 
including a proton-gated anion-channel (GLIC) and a putative anion-channel 
(ELIC), for which an agonist has yet to be identified (Bocquet et al., 2009: Hilf 
and Dutzler, 2009; 2008). These findings confirm the prevalence of Cys-loop 
receptors in prokaryotes. 
 
1.4 GABA 
 
GABA has long been known to exist in plants and bacteria, where it serves a 
metabolic role in the Krebs cycle; it is synthesized by decarboxylation of 
glutamate by the enzyme glutamic acid decarboxylase. In the 1950s GABA 
was discovered to be a free amino acid in the brain (Roberts and Frankel, 1950) 
(Fig. 1.1) and GABA was accepted as a neurotransmitter following the 
observation that GABA application inhibits Ascaris body muscles by opening 
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chloride channels (Del Castillo et al., 1963). It is now known that these actions 
of GABA are mediated by a GABA-gated chloride channel, the GABAA 
receptor (Schofield et al., 1987). In vertebrate neurons the activation of 
GABAA receptors usually permits the diffusion of chloride ions into the cell, 
hyperpolarising the membrane and decreasing the excitability of the cell.  
 
 
 
Figure 1.1 Chemical structure of GABA (γ-amino-butyric acid). GABA is a carboxylic 
acid with a pKa of 4.03. At typical physiological pH, the amino group is protonated and the 
carboxylate carries a negative charge (Huxtable et al, 1987). 
 
1.5 GABAA   receptor structure 
 
GABAA receptors are ionotropic ligand-gated ion channels consisting of five 
subunits which can be assembled with varying stoichiometries. To date, 19 
mammalian GABAAR subunits have been isolated by cDNA cloning; 6α, 4β, 
3γ, 1δ, 1ε and 3ρ subunits. For distinction, receptors consisting of only ρ 
subunits are referred to as GABACRs, although these receptors are technically a 
sub-class of GABAARs (Barnard et al., 1998). The α1 subunit is the most 
abundant isoform in the adult mammalian brain (Luque et al., 1994) whilst α2 
and α3 subunits are found predominantly in the spinal cord (Persohn et al., 
1991). β subunits co-express with α and γ subunits, with the γ subunit 
conferring benzodiazepine sensitivity. δ subunits and γ subunits co-express 
with α and β subunits and the predominant isoform in the mammalian brain 
includes 2α1 and 2β2/2β3 subunits, along with either δ or γ subunits (Somogyi et 
al., 1996). ρ subunits are localised within retinal bipolar cells, with only low 
densities found in the brain (Cutting et al., 1992; Cutting et al., 1991; Enz and 
Cutting, 1999). Each subunit consists of a large extracellular, ligand-binding, 
domain, a transmembrane domain containing four membrane-crossing α-
helices (M1–M4) and a large M3–M4 intracellular loop (See Fig. 1.2). The 
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second transmembrane spanning regions (M2) are arranged centrally, forming 
the water-filled, channel pore. Loops within the extracellular domain are 
involved in ligand binding and are named A to F (Fig. 1.2 & Fig. 1.3). 
Receptors consist of a pseudo-symmetrical arrangement of subunits within the 
neuronal membrane (Fig. 1.4). 
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Figure 1.3 Schematic of a Cys-loop receptor. Loops within the extracellular domain are 
labelled by using common nomenclature A-to-F. Four transmembrane spanning regions are 
labelled M1, M2, M3 and M4. A large intracellular loop extends between transmembrane 
regions M3 and M4. Subunits form a pentameric arrangement to yield a complete receptor.  
Taken from Thompson and Lummis, 2007, with copyright permission granted from Expert 
Opinion on Therapeutic Targets.  
  
Acetylcholine binding protein (AChBP), is a soluble acetylcholine scavenging 
protein which is secreted by glial cells in the fresh water snail Lymnaea 
stagnalis (Smit et al., 2001). This protein is homologous to the nicotinic 
acetylcholine receptor and other Cys-loop receptors (See in Fig. 1.2). The 
crystal structure of this protein at 2.7 Å resolution has thus yielded insight into 
the structure of the extracellular domain of Cys-loop receptors (Brejc et al., 
2001). Additionally, the structure of the extracellular domain of the nAChR α1 
subunit has been solved to 1.9 Å (Dellisanti et al., 2007). These advances have 
led to the prediction that the extracellular domains of homologous Cys-loop 
receptors would be predominantly β-sheet in structure. Electron micrograph 
images of the full length AChR from the electric organ of the Torpedo ray at 4 
Å resolution have revealed the structure of the full receptor (Miyazawa et al., 
2003) showing the transmembrane regions to be α-helical (Fig. 1.4). 
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Figure 1.4 Structure of a Cys-loop receptor. Above: Ribbon structure of the refined 
structure of the acetylcholine receptor from the electric organ of the Torpedo ray at 4 Å 
resolution (pdb ID: 2bg9) (Miyazawa et al., 2003). Two of the five subunits are displayed in 
atomic stick format to enhance perspective. Individual subunits are labelled red, yellow and 
green for distinction. The extracellular domain is largely β-sheet and the transmembrane and 
intracellular domains are α-helical. Below: Pore view of the receptor from the extracellular 
perspective. Five subunits (labelled grey, blue, green, red and yellow for distinction) form a 
pentameric arrangement to yield a complete receptor.   
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1.6 Receptor activation 
 
1.6.1 Gating 
 
Gating refers to the mechanism of transduction which links agonist binding at 
the extracellular domain to the opening of the channel gate some 50 Å away. 
To facilitate comparison between the channel-lining residues of the second 
transmembrane domain (M2) of different Cys-loop receptor channels, a prime 
number notation is used starting with the highly conserved positively-charged 
residues at the cytoplasmic end of M2, defined as 0′, increasing to another ring 
of charged residues at the extracellular end denoted as 20′ (Miller, 1989). The 
gate is deemed to be located at the “hydrophobic girdle” between M2 residues 
9' and 14' (Bali and Akabas, 2007; Miyazawa et al., 2003; Panicker et al., 
2002). The free energy derived from the binding of agonist to its binding site in 
the extracellular domain induces a conformational change which is transmitted 
to the gate and causes opening of the ion channel. Whilst most of the studies of 
channel gating have been done on AChRs, I will discuss studies from a range 
of receptors to illustrate the similarities across receptor types. Such studies can 
provide clues as to the mechanisms which underlie Cys-loop receptor function 
in general terms.  
 
Linear free-energy relationship analysis of mutant nAChRs has shown that a 
local conformational change in the binding site is propagated as a 
conformational wave to the channel (Grosman et al., 2000). An in-silico study 
of loop C, which forms part of the ligand binding site, in the human α7 
nicotinic acetylcholine receptor (nAChR) described initial coupling between 
ligand binding and channel gating (Cheng et al., 2006); these targeted 
molecular dynamic (MD) simulations suggest that gating movements of the α7 
receptor may involve relatively small structural changes within loop C of the 
ligand-binding domain. A more recent structural study of AChBP, co-
crystallised with agonists and antagonists bound, shows a ‘capping’ motion of 
loop C closing the binding site cavity, thereby trapping bound agonist 
molecules. Residues at the apex of loop C moved inwards as much as 7 Å with 
agonists bound. However, antagonists caused loop C to move outwards as 
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much as 4 Å providing a mechanism underlying their inhibitory effects (Hansen 
et al., 2005). These findings agree with the previous modelling of Cheng et al 
for nAChRs, but the magnitude of loop C movement presented by Hansen 
would suggest that loop C undergoes larger movements during agonist binding 
than previously suggested.  
 
Environment-sensitive fluorescent probes have been used to identify residues 
involved in the gating mechanism. When the agonist is applied, changes in 
fluorescence can be monitored and related to conformational changes involved 
in gating. A recent study of the GlyR by Lynch and Pless (2009) showed that 
most fluorescently labelled residues in loops C and F yielded fluorescence 
changes identical in magnitude for glycine and strychnine (a GlyR antagonist) 
but distinct maximal fluorescence responses for labels on loops D and E. A 
similar study of GABAARs has shown that homologous residues within loop E 
of both β and α subunits display a similar fluorescence change during gating 
(Muroi et al., 2006), suggesting a similar structural transition occurs in both 
subunits. A follow on study by the same authors showed that residues in loop D 
(α1L127C and β2L125C) also produce an increase in fluorescence in response 
to GABA binding (Muroi et al., 2009). This presents the hypothesis of a 
‘global transition’ with similar movements in different subunits occurring 
during channel gating. 
 
Agonist binding causes changes at the extracellular domain which are thought 
to induce a structural transition which causes a widening of the channel pore, 
formed by the five M2 helices. Indeed, images of the nAChR trapped in the 
open state showed that the M2 rods were tilted outwards from their resting 
configuration (Unwin, 1995). The kinks in the α-helices facing the channel 
pore (M2-region) had rotated to face the side, increasing the pore diameter by 
about 4 Å. With the solution of the crystal structures of related prokaryotic 
Cys-loop receptors - ligand gated ion channels from a bacterium (ELIC) (Hilf 
and Dutzler, 2008) and from a cyanobacterium (GLIC) (Hilf and Dutzler, 
2009), a similar channel in a putatively open conformation - the pore structure 
in putatively both open and closed states has been revealed. Examining the 
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differences in pore structure between these two receptors suggests that the M2 
helices relax and tilt around their M2 longitudinal axis with a widening of the 
channel at the extracellular end (Fig. 1.5). Studies of nAChRs support this 
hypothetical transition: a fluorophore attached to nicotinic acetylcholine 
receptor β M2 region (a Cys side chain introduced at the β 19' position in the 
M2 region) has been used to detect productive binding of agonist in the 
nAChR. During agonist application, fluorescence increased by approximately 
10%, and the emission peak shifted to lower wavelengths, indicating a more 
hydrophobic environment for the fluorophore (Dahan et al., 2004). A more 
recent study of the muscle AChR suggests that small structural rearrangements 
may underlie channel opening. Ionisable amino acids were engineered into M1 
and M3 and the effects on channel gating were monitored. The effect of proton 
transfer was determined using single-channel electrophysiology and it was 
determined that the M2 helices move by no more than 1.5 Å (Cymes and 
Grossman, 2008). This prediction is supported by computational approaches 
which predict that a 1.5 Å widening of the pore is sufficient to increase the 
channel conductance to values that are close to those observed experimentally 
(Corry, 2006).  
 
In 5-HT3 receptors an essential proline residue has been identified which has 
been shown to undergo a trans-cis isomerisation during gating which is 
necessary for channel opening. This study was carried out using unnatural 
amino-acid mutagenesis where the proline 8* residue was replaced with proline 
analogues favouring the trans conformer. The trend observed showed that the 
trans conformer prevented channel gating (Lummis et al., 2005a). This 
suggests a possible “switching mechanism” for channel gating revolving 
around the isomerisation of the proline 8* residue. This proline residue is not 
however present in GABA or glycine receptors, thusly confounding the 
possibility of a unified model for channel gating for all LGICs. 
 
There is some disagreement in the literature regarding the magnitude of the 
structural transitions underlying receptor activation, however there is a 
common agreement amongst many studies; a structural rearrangement amongst 
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extracellular binding site loops leads to a structural transition which causes a 
widening of the channel pore leading to ion flux. While specific residues may 
take on different roles in different receptors, it seems that this overview is 
appropriate for many, if not all, of the Cys-loop receptors. 
 
Figure 1.5 Examination of the pore structure of GLIC and ELIC, prokaryotic Cys-loop 
receptors, in putative open and closed states, respectively. Above: Two adjacent M2 
regions of the pore with channel-lining residues labeled and side chains in stick 
representation.  A difference in the M2 helical axis is obvious with a tilting away from the 
pore at the extracellular end of GLIC. Below: View of the channel pore from the extracellular 
position. M2 residues are in the space filling representation to demonstrate the pore cavities 
dimensions. A wider pore is observed in GLIC suggesting that the tilting of the helices results 
in a widening of the channel pore. 
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1.6.2 Interface residues 
 
Studies of the regions which bridge the extracellular and transmembrane 
domains have led to the identification of several critical “interface residues.” 
Structures from the extracellular domain which constitute this interface include 
the β1-β2 loop, the Cys-loop, the β8-β9 loop and the end of the β10 loop. The 
pre-M1 region, the M2-M3 linker and the C-terminal of M4 are also involved 
in this interface (Fig. 1.6) (Bartos et al., 2009a). 
 
Studies of chimeric receptors composed of AChBP tethered to the pore domain 
of the 5-HT3AR has led to an understanding of some of these coupling regions. 
Whilst the chimera is expressed at the cell surface, binding of ACh is unable to 
trigger channel opening, however with the substitution of three regions (β1-2 
loop, Cys-loop and β8-9 loop) in AChBP, ACh binds with lower affinity but is 
capable of triggering channel opening (Bartos et al., 2009a). It has also been 
demonstrated that the ECD of α7 AChRs can be successfully coupled to the 5-
HT3AR, as the ECD of α7 has similar interface residues (Bouzat et al., 2008) 
(Fig. 1.6). This construct has proven to be a good model for studying the role of 
interface regions, leading to the hypothesis that activation depends on a 
“complex network of loops,” where specific interactions between interface 
residues can not always be successfully substituted with loops from other 
receptors (Bouzat et al., 2008). 
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Figure 1.6 The interface between extracellular and transmembrane domains. Above: a 
structure of the Torpedo nAChR with one of its subunits highlighted with the extracellular 
domain in yellow and the transmembrane and intracellular domains in red. The interface is 
shown in the dashed square. b View of the structures at the interface. Left: The different 
segments are coloured as follows: orange (β1-2 loop), ice blue (β8-9 loop), green (Cys-loop), 
purple (β10-terminal), pink (pre-M1), blue (M2-M3 linker), and cyan (post-M4). Right: 
Surface representation of the interface loops. c Different views of the interface with key 
residues labelled. Ile210 in Torpedo nAChR corresponds to Leu210 in the human receptor. 
Below: Subunit sequences at the receptor interface. Taken from Bartos et al., 2009a. with 
copyright permission from Mol. Neurobiol. 
 
Similar work on GABAA  receptors has shown that receptor activation depends 
on electrostatic interactions between charged residues in the β1-2 loop and the 
Cys-loop (Asp57 and Asp149) as well as Lys279 in the M2-M3 linker (Kash et 
al., 2003). An equivalent residue in the 5-HT3AR (Lys81 in the β1-2 loop) lies 
close to the extracellular end of M2 (26'A and 27'I) and mutational analysis has 
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shown that this residue is involved in channel opening (Reeves et al., 2005). In 
the GABACR, residue Glu92, situated in the β1-2 loop has been shown to form 
a salt-bridge with pre-M1 residue Arg258 (Price et al., 2007; Wang et al., 
2007). In the same study it was shown that this specific interaction is absent in 
the 5HT3AR (Price et al., 2007). 
 
An interaction between residues in the pre-M1 and the M2-M3 linker has been 
identified in the human muscle nAChR. It was suggested that agonist binding 
disrupts a salt-bridge between pre-M1 Arg209 and Glu45 in the β1-2 loop, 
which in turn triggers a wave of interactions which propagate towards the 
channel (Lee and Sine, 2005). This hypothesis is supported by a related study 
which showed that Arg209 and Glu45 move early during the gating process 
(Purohit and Auerbach, 2007). Recent studies investigating the sequence of 
movements of residues during gating has led to the construction of a Φ map, 
which suggests that agonist binding triggers motions which causes a movement 
of the Cys-loop and β1-2 loop, followed by the M2-M3 linker, several M2 
residues and finally the gate at the channel pore (9'-14' region) (Bafna et al., 
2008; Chakrapani et al., 2004; Grutter et al., 2005; Zouridakis et al., 2009) 
 
The coupling of agonist binding to channel opening some 50 Å away involves 
several conserved regions, particularly the pre-M1 region, loop C and loop β1-
β2. Though specific residues and interactions seem to vary across receptor 
types, there seems to be an overall degree of similarity across the Cys-loop 
family, suggesting a conserved mechanism of receptor gating. 
 
1.6.3 Kinetic schemes 
 
Kinetic schemes have been posited which fit the observed single-channel 
behavior of Cys-loop receptors. Most of these schemes have been for the 
nAChR and GlyR, which are amenable to single-channel analysis (Auerbach, 
2010; Lape et al., 2008; Sine and Engel, 2006). Sine describes a “primed” state 
which precedes channel opening at the nAChR (Mukhtasimova et al., 2009) 
(Figure 1.7). The channels’ closed to open transition is agonist-independent and 
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is preceded by two primed closed states; the singly primed state has an 
intermediate duration and triggers brief openings, whereas the doubly primed 
state has a brief duration and triggers long-lived openings. The priming step is 
thus a spontaneous transition that occurs after agonist binding. Similarly, 
Colquhoun describes a “flip” state of the GlyR, “a structural change which 
takes place while the channel is still shut.” This suggests that there is a 
structural change which occurs after agonist has bound but before the channel 
has opened.  Both of these schemes suggest that a structural transition occurs 
which precedes channel opening and that initial binding of a ligand can 
influence the binding of subsequent ligands to adjacent binding sites. A similar 
conformational change for the high-conductance isoform of the 5-HT3AR has 
been reported (Corradi et al., 2009), suggesting that this may be a conserved 
mechanism across the Cys-loop receptor family.  
 
 
 
Figure 1.7 Kinetic scheme for Cys-loop receptor activation. Agonist binding, priming and 
channel gating steps are shown. C, C' and C'' symbolize closed states, whereas O' and O'' 
symbolize open states. A symbolises an agonist molecule. In the absence of agonist, the C' 
and C'' states are negligible, indicating that the first step in the activation process generates 
AC, from which there are three possible paths towards A2C''. Taken from Mukhtasimova et 
al., 2009, with copyright permission from Nature. 
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A structural study of AChBP described how agonists stabilise loop C in a fully 
contracted state, whereas peptide inhibitors stabilise loop C in a fully extended 
conformation (Ulens et al., 2009). This study utilised the strategy of co-
crystallisation of AChBP with bound agonists and antagonists. These data, 
demonstrating a structural rearrangement of loop C following agonist binding, 
support the theoretical “flip” or “primed” states described by Colquhoun and 
Sine. Indeed, by providing a structural explanation of such transition states, 
Ulens has shown how such mechanisms may be part of Cys-loop receptor 
gating. 
 
Gating of the Cys-loop receptors seems to involve small structural changes at 
the ligand binding site which cause a change in the stability of the closed state 
of the M2 helices. The opening of the gate is dependant on this structural 
change. Whilst the basic mechanism for gating is generally understood, all of 
the intricate molecular determinants have yet to be characterised. There has 
thus yet to be posited a unified model of gating dynamics for all members of 
the Cys-loop family. 
 
1.7 Ligand binding site 
 
The agonist binding site is located in the extracellular region at the interface 
between adjacent subunits. There is thus a theoretical maximum of five agonist 
binding sites per receptor. The binding site is comprised of six discontinuous 
loops (A-F). The ligand binds between Loops A, B and C, on the principal 
subunit, and loops D, E and F on the complementary subunit (Akabas, 2004) 
(Figure 1.8). 
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Figure 1.8 Extracellular domain of a Cys-loop receptor. The ligand-binding site is 
comprised of residues from loops A, B and C from the principal subunit and D, E and F from 
the complementary subunit. 
 
Functional experiments show that many Cys-loop receptors have a Hill 
coefficient greater than one - suggesting cooperativity - indicative of more than 
one agonist binding site per receptor. Single-channel experiments for the 5-
HT3AR have led to the hypothesis that three occupied ligand binding sites lead 
to maximal receptor activation (Corradi et al., 2009). A similar study in the 5-
HT3AR showed that receptors with three binding sites at non-consecutive 
subunit interfaces exhibit maximal mean channel open time and receptors with 
binding sites at three consecutive or two non-consecutive interfaces exhibit 
intermediate open time. However, receptors with binding sites at two 
consecutive or one interface exhibit a brief open time (Rayes et al., 2009). The 
increased receptor activity associated with the occupation of non-consecutive 
binding sites suggests that the structural rearrangement inherent in channel 
opening involves movements within the extracellular domains which affect 
adjacent binding sites. This hypothesis of ‘structural transitions’ is supported 
by voltage-clamp fluorometry studies of the GlyR (Pless and Lynch, 2009a; 
2009b; 2009c) which show that an agonist specific structural change occurs in 
the loops of the extracellular domain that is correlated with agonist efficacy.  
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Many residues involved in binding GABA in the GABAA receptor have been 
identified within the extracellular binding site loops. In particular, hydroxylated 
residues, aromatic residues and charged residues have been identified as being 
important in ligand binding. Several aromatic residues which form an 
“aromatic box,” a hydrophobic surface favourable for ligand stabilisation, have 
been identified: α1Phe64, β2Tyr62, β2Tyr97 and β2Tyr205. Hydroxylated 
residues α1Ser68, β2Thr160, β2Thr202, β2Ser204 and β2Ser209 are critical for 
ligand binding. Charged residues are also involved in GABA binding: 
α1Arg120, α1Asp183, α1Arg66 and β2Arg207. These residues probably stabilise 
the carboxylate moiety of the ligand (Amin and Weiss, 1993; Boileau et al., 
2002; Newell and Czajkowski, 2003; Wagner et al., 2004; Westh-Hansen et al., 
1997; Westh-Hansen et al., 1999). A different repertoire of residues which are 
involved in GABA binding have been identified in the GABAC receptor: 
Tyr102, Arg104, Tyr106, Phe138, Val140, Arg158, Tyr198, Phe240, Thr244 
and Tyr247 (Amin and Weiss, 1994; Harrison and Lummis, 2006; Lummis et 
al., 2005b; Zhang et al., 2008). Similarly to the GABAA receptor, these 
findings suggest an important role for aromatic, hydroxylated and charged 
residues in the GABAC receptor binding site. A review of GABA binding sites 
has described these data recently (See Lummis, 2009). In GABAA receptors 
GABA binds in a partially folded conformation, whilst in GABAC receptors it 
is in an extended conformation (Jones et al., 1998; Woodward et al., 1993). 
Although conformations of GABA within the binding sites of different GABA 
receptors varies somewhat, an overall similarity of location seems to be 
conserved. 
 
1.8 Insect GABA receptors 
 
Insect GABA receptors are one of the major targets of insecticides (Raymond-
Delpech et al., 2005) and Fipronil, an antagonist of insect GABA receptors, is 
one of the most important insect control chemicals to date (Sammelson et al., 
2004). Other insecticides such as α-endosulfan and lindane target GABA 
receptors as a means of inducing a lethal convulsant state within their pestilent 
targets (Chen et al., 2006).  
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Several transcripts have been identified in D.melanogaster which may form 
GABA-gated anion channels. Whilst transcripts CG6927, CG7589, CG11340, 
and CG12344 have not yet been functionally assessed (Buckingham et al., 
2005), transcripts RDL, GRD and LCCH3 have been heterologously expressed 
and assessed functionally. These three oligomeric invertebrate GABA receptor 
subunits have a similar degree of sequence homology with the characterised 
vertebrate GABAA receptor subunits as they do with each other (30-
38%)(Hosie and Sattelle, 1996a)(Figure 1.9). These insect GABA receptor 
subunits form heteromeric receptors with varying properties when expressed 
heterologously (Gisselmann et al., 2004; Hosie et al., 1997) (Table 1.1). It has 
been shown that GRD and LCCH3 coassemble to form GABA-gated cation 
channels when cRNA is co-injected into Xenopus laevis oocytes (Gisselmann 
et al., 2004). This suggests that RDL may play an important role in the 
formation of heteromeric GABA receptors. Furthermore, RDL orthologues 
have been identified in many other insect species; examples include the house 
fly (Eguchi et al., 2006), red flour beetle (Jones and Sattelle, 2008), honeybee 
(Dupuis et al., 2010), German cockroach (Kaku and Matsumura, 1994), and 
mosquito (Du et al., 2005). Furthermore, RDL receptors from the mosquito, 
cockroach and small brown planthopper have been functionally assessed 
(Shotkoski et al., 1994; Shotkoski et al., 1996; Eguchi et al., 2006; Narusuye et 
al., 2007). 
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Figure 1.9 A dendrogram illustrating the relative similarity of known insect GABA 
receptor subunits and other ligand-gated anion-channels. Vertebrate GABA receptor 
subunits are marked α,β, etc., GLY refers to GlyR subunits while Glu Cl – and Hc G1 refer to 
glutamate-gated chloride-channels and a putative GABAR or GlyR subunit from 
Haemonchus contortus. The RDL subunit is most closely related to vertebrate GABAA ρ 
subunits. Taken from Hosie et al., 1997, with copyright permission from Trends in 
Neurosciences. 
 
Table 1.1 Pharmacology of insect GABA receptor subunits when co-expressed and 
expressed alone. 
Subunit 
combination 
Heterologous 
expression 
Pharmacology 
 
Reference 
 
RDL homomer  Oocytes, Sf-21; 
S2 
Picrotoxinin-sensitive; 
Bicuculline-insensitive  
(Hosie et al., 1996; Millar 
et al., 1994; Buckingham 
et al., 1994; Lee et al., 
1993; ffrench-Constant et 
al., 1993a) 
RDL + LCCH3  Oocytes, Sf-21 Picrotoxinin-insensitive; 
Bicuculline-sensitive  
(Zhang et al., 1995b) 
RDL + GRD  Not reported  Not reported  N/A  
GRD + LCCH3  
 
Oocytes 
 (cation channel)  
Picrotoxinin-sensitive; 
Bicuculline-insensitive  
(Gisselmann et al., 2004) 
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Native insect GABA receptors are insensitive to the GABAA competitive 
antagonist bicuculline and sensitive to GABAA receptor agonists 3-
aminopropanesulfonic acid (3-APS), isoguvacine, muscimol and the GABAA 
and Glycine non-competitive antagonist picrotoxin (Buckingham et al., 1994). 
This pharmacology distinguishes them from both vertebrate GABAC receptors, 
where 3-APS is an antagonist, and GABAA receptors which are sensitive to 
bicuculline and show sensitivity to many allosteric modulators (Sieghart, 1995; 
Hosie and Sattelle, 1996b). Insect GABA receptors are also sensitive to a range 
of non-competitive antagonists including Fipronil, TBPS and EBOB 
(Buckingham et al., 1994). The replacement of alanine 302 with serine or 
glycine in all subunits encoded by the rdl gene renders RDL-containing 
receptors 100-fold less sensitive to PTX than wild-type (ffrench-Constant et al., 
1993a). RDL forms picrotoxin insensitive receptors when expressed with 
LCCH3 (Zhang et al., 1995b), suggesting that LCCH3 is the predominant 
subunit in these heteromers. However, when LCCH3 is coexpressed with GRD, 
picrotoxin sensitivity is restored on the cationic GABA-gated channel 
(Gisselmann et al., 2004). RDL is the best studied of these subunits as it can be 
expressed readily in Xenopus oocytes where it forms functional homomers with 
pharmacology similar to that of native insect neurons (Zhang et al., 1994). As 
such, RDL receptors are considered to be pharmacologically representative of 
insect GABA-gated ion channels in general. 
 
1.9 RDL receptors  
 
The RDL subunit was originally identified in mutant D.melanogaster strains 
showing resistance to the insecticide dieldrin, hence the name “RDL” (ffrench-
Constant et al., 1991; ffrench-Constant et al., 1993b). Dieldrin blocks the 
channel of RDL receptors and an Ala to Ser mutation was identified in the pore 
lining M2 region (Ala302), which conferred resistance. RDL receptor subunits 
in D. melanogaster can occur as a variety of different splice variants resulting 
in varying agonist sensitivities (Buckingham et al., 2005; Hosie et al., 2001; 
Hosie et al., 2001). The regions which are modified lie in exons 3 and 6 (Fig. 
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1.10). These alternative transcripts are named a, b (exon 3), c and d (exon 6). 
The RDLac variant is considered the canonical isoform and this is the isoform 
used in this study. 
 
 
 
 
Figure 1.10 Regions of rdl (the gene for the RDL subunit) which are alternatively 
spliced. Exons 3 and 6 undergo alternative splicing resulting in altered agonist sensitivity 
(Buckingham et al., 2005). Exons 3 and 6 correspond to extracellular loops D and F 
respectively. Reproduced with permission, from McGonigle et al., 2009, Biochemical Society 
Transaction, (Pt 6):1404-6. © the Biochemical Society (http://www.biochemsoctrans.org). 
 
RDL receptors were first expressed heterologously in Xenopus oocytes by 
ffrench-Constant et al. (1993a) and then in an insect cell line (S2 cells) by 
Millar et al. (1994). More recent studies have focussed on the role of 
alternative splicing in this receptor subunit; indeed, studies on the three cloned 
splice variants of rdl have revealed differences in agonist potency with GABA 
EC50s of 9-30, 56-60 and 100-150 µM for the ac, ad and bd splice variants, 
respectively (Buckingham et al., 2005; Hosie and Sattelle, 1996a), suggesting 
that the variant residues are involved in receptor activation. Since these spliced 
regions lie in the extracellular domain, close to the binding site of all Cys-loop 
receptors, alterations in this region could reduce agonist affinity and/or gating 
efficacy. 
 
Heterologously expressed RDL receptors have similar characteristics to GABA 
receptors of cultured Drosophila neurons (Zhang et al., 1994), and RDL 
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subunits are widely distributed throughout the adult and embryonic Drosophila 
CNS (Aronstein and ffrench-Constant, 1995; Harrison et al., 1996; Hosie et al., 
1997); thus it is reasonable to assume that these receptors play a major role in 
inhibitory neurotransmission in the insect CNS. Indeed it has been shown using 
RNA knock down that RDL receptors are essential to olfactory learning and the 
associated conditioned stimulus pathway in Drosophila (Liu et al., 2009; Liu 
and Davis, 2009). A more recent study has shown, using gene knockdown, that 
RDL has a role in learning in Drosophila and in particular RDL negatively 
modulates olfactory associative learning (Liu et al., 2007). This highlights the 
functional importance of RDL in insect neuronal signalling. This study also 
provided high quality immunocytochemical staining images of RDL 
distribution throughout the fly brain, showing RDL expression to be distributed 
widely, with RDL receptors detected on neuronal dendrites and axons but not 
cell bodies. Nonetheless, RDL receptors were detected widely throughout the 
antennal lobes and mushroom bodies. 
 
It has been shown that RDL subunits can also coassemble with glutamate 
receptor subunits to form functional GABA-gated anion channels (Ludmerer et 
al., 2002). Since RDL can form heteromeric receptors with both Glutamate 
receptors as well as other insect GABA receptor-subunits (Gisselmann et al., 
2004) (Table 1.1), it probably plays a role in the insect CNS, potentially 
generating a diverse set of GABA receptors. Studies of single-channel 
properties of RDL containing GABA receptors from cultured Drosophila 
neurons are similar to those of RDL homomers (Zhang et al., 1995b); the 
single-channel conductance for inward currents was 21 pS for RDL homomers, 
versus 28 pS for GABA receptors on cultured neurons (Zhang et al., 1994).  
The distribution of putative RDL-like GABA receptors has been demonstrated 
in the brain of the adult house cricket Acheta domesticus, using specific antisera 
(Strambi et al., 1998) (Fig. 1.11). The mapping of RDL subunits using RDL-
specific anti-sera confirms the widespread distribution of RDL containing 
GABA receptors in the insect nervous system, similarly to that shown in 
Drosophila (Liu et al., 2009). 
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Figure 1.11 Distribution of RDL receptors in the adult house cricket Acheta domesticus.  
Diagram summarising, in frontal view, the distribution of RDL-like GABA receptors (right) 
and of the GABA-like immunoreactivity (left). Except for the mushroom bodies, 
immunoreactivity in the neuropils has been omitted for clarity. Nine groups (I-X) of 
GABAergic neurons were indicated as well as neurons immunoreactive to the RDL-GABA 
receptor subunit antiserum. (AC) Anterior calyx of mushroom body; (PC) posterior calyx of 
mushroom body; (P) peduncle of mushroom body; (α) α lobe of mushroom body; (β) β lobe 
of mushroom body; (AL) antennal lobe; (CB) central body; (OL) optic lobe; (PI) pars 
intercerebralis; (AN) antennal nerve; (AMC) antennal motor center; (DLP) dorsolateral 
protocerebrum; (VLP) ventrolateral protocerebrum. Taken from Strambi et al., 1998, with 
copyright permission granted from Cold Spring Harbour Laboratory Press. 
 
RDL subunits are homologous to GABAA, glycine, 5-HT3 and nACh receptors 
(Dougherty, 2008) (See Fig. 1.2). Extrapolation from vertebrate receptor data 
suggests that all of these proteins are pentameric, consisting of five subunits 
arranged pseudo-symmetrically around a central ion pore (Miyazawa et al., 
2003; Sine and Engel, 2006). RDL however has a larger M3-M4 intracellular 
loop than its vertebrate orthologues, containing some 86 more residues (See 
Fig. 1.2). There is as yet no structural information available for RDL receptors, 
however we have recently published a homology model of the RDL 
extracellular domain based on AChBP, which shows a range of agonists 
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docked into the agonist binding site and predicts a range of ligand-receptor 
interactions (McGonigle and Lummis, 2010) (See Fig. 1.12).  
 
Figure 1.12. Model of the extracellular domain of RDL. Above RDL extracellular domain 
dimer. A 3D homology model of the extracellular domain of an RDL GABA receptor based 
on the crystal structure of AChBP (pdb: 1i9b) at 2.7 Å resolution. Extracellular loops A-F 
contribute to the agonist binding site. A GABA molecule is docked close to loops A, B and C. 
Below: Sequence alignment of RDL and related Cys-loop receptors. Aromatic residues that 
contribute to the binding pocket in the RDL receptor have mostly aromatic residues in the 
equivalent locations in other Cys-loop receptors. Taken from McGonigle et al., 2010, with 
copyright permission from ACS Biochemistry. 
 
RDL receptors are widely accepted as a good model for the behaviour of insect 
GABA receptors (Buckingham et al., 2005). They mimic closely the 
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pharmacology of native insect GABA receptors (Buckingham et al., 1994) and 
RDL receptors are located widely in the insect CNS (Sattelle et al., 2000; 
Strambi et al., 1998). Insect GABA receptors are also the major site for 
insecticide action (Buckingham et al., 2005; Casida, 1993; Casida, 2009) and 
RDL receptors expressed in Xenopus oocytes represent an effective 
insecticide/drug screening platform. RDL receptors are thus a model system for 
studying insect GABA receptors and Cys-loop receptors in general. By 
characterising RDL receptors we will gain a greater insight into the 
mechanisms underlying agonist binding as well as receptor function. Achieving 
a clear understanding of the determinants of the agonist binding site in RDL 
receptors will be a great aid in the rational design of RDL-specific antagonists, 
potentially paving the path to a new wave of selective insecticides as well as a 
greater understanding of insect GABA receptors. 
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2.0 Thesis Aims 
 
In this thesis I use biophysical, pharmacological, and computational methods as 
well as site directed mutagenesis to assess the structure and function of RDL 
receptors. 
 
In chapter 3 I determine the biophysical properties of wild-type RDL receptors 
using electrophysiological methods, assessing pH sensitivity, ionic selectivity 
and expression rates of receptors. In chapter 4 I report a structure-activity study 
of the agonist binding site, testing the potency of a range of GABA analogues 
and performing molecular modelling and docking simulations at the binding 
site. In chapter 5 I utilise site-directed mutagenesis and functional studies to 
assess the accuracy of my model of the binding site model. In chapter 6 I assess 
the potency of Ginkgo biloba extracts on RDL receptor function and use 
mutagenesis and molecular modelling to assess the nature of the binding 
interaction. In chapter 7 I assess the functionality of two brain-derived 
transcripts of the 5-HT3B subunit (Br1 and Br2) using electrophysiological and 
fluorometric methods. 
 
The overall aim of this thesis is to achieve a greater understanding of how Cys-
loop receptors function at a molecular level.  
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Chapter 2 
 
Materials & Methods 
______________________________________________ 
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Materials 
 
 
2.1 Suppliers and addresses 
 
Ambion UK [Applied Biosystems], Lingley House, 120 Birchwood 
Boulevard, Warrington, WA3 7QH, UK 
Bruxton Corporation, 6416 34th Ave, NW Seattle, WA 98107-2607, USA 
Dow Corning Corporation, Corporate Centre, PO Box 994, MIDLAND MI, 
48686-0994, USA 
Garner Glass, 91711- 4921 Claremont, CA, USA 
Gibco [Invitrogen Ltd], 3 Fountain Drive, Inchinnan Business Park, Paisley, 
PA4 9RF, UK 
GraphPad Software, 2236 Avenida de la Playa, La Jolla, CA 92037, USA 
Greiner, Brunel Way, Stroudwater Business Park, Stonehouse, GL10 3 SX, 
UK 
Harvard Apparatus Ltd, PO BOX 126, Edenbridge, Kent TN8 6WF, UK 
Labtech, 1 Acorn house, The Broyle, Ringmer, East Sussex, BN8 5NN, UK 
Molecular Devices UK, Winnersh Triangle, 660-665 Eskdale Road, 
Wokingham, Berkshire, RG41 5TS, UK 
Molecular Devices US, 1311 Orleans Drive, Sunnyvale, CA 94089-1136, 
USA 
National Instruments, 11500 N Mopac Expwy, Austin, TX 78759-3504, USA 
NEB (New England Biolabs), 240 County Road, Ipswich, MA 01938-2723, 
USA 
Qiagen, QIAGEN House, Fleming Way, Crawley, West Sussex, RH10 9NQ, 
UK 
Sigma-Aldrich Company Ltd., The Old Brickyard, New Road, Gillingham, 
Dorset, SP8 4XT, UK 
Stratagene [Agilent Technologies, UK], South Queensferry, West Lothian, 
EH30 9TG, UK 
Sutter Instrument Company, One Digital Drive, Novato, CA 94949, USA 
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Methods 
 
 
 2.2 Subcloning of rdl into pGEMHE  
 
RDL subunit cDNA (GenBank accession number P25123) was gifted by 
N.Millar. The rdl gene (ac splice variant) was subcloned from pcDNA3.1 
(Gibco: Invitrogen) into pGEMHE, the Xenopus oocyte expression vector, 
using the restriction sites AflII and XbaI; the pGEMHE vector contains 3'- and 
5'-untranslated regions of a Xenopus β-globin gene, which has been shown to 
facilitate very high expression of a number of exogenous proteins in Xenopus 
oocytes (Liman et al., 1992). Positive clones containing the rdl gene insert 
were detected by carrying out restriction digests.  
 
2.3 Preparation of mRNA 
 
20 µg wild-type DNA in pGEMHE was linearised by digestion with Nhe1 HF 
(NEB) in 50 µL volume. 2 µL of proteinase K (1 mg/mL) was added to the 
reaction mixture and the sample was incubated at 37°C for 1 h in order to 
degrade any protein in the cDNA sample. DEPC treated water was added to 
give a final volume of 300 µL. DNA was purified with one phenol/chloroform 
extraction followed by one chloroform extraction. DNA was precipitated by the 
addition of 0.1 volumes 3M sodium acetate and 3 volumes 100% ice-cold 
ethanol. The mixture was left at -20°C for at least 1 h. DNA was pelleted by 
centrifugation for 15 min at 13,000 g at 4°C. The pellet was washed with 70% 
ethanol, air dried and resuspended in 10 µL DEPC water. Linearised DNA was 
diluted to 1 mg/mL and 1 µL was used for an in vitro transcription reaction 
using T7 mMESSAGE mMACHINE kit (Ambion). cRNA concentration was 
determined by measuring the A280 of a diluted aliquot of mMESSAGE product 
(2 µL diluted in 500 µL ddH2O) using a benchtop spectrophotometer, taking 
the original template cDNA into account. An aliquot of cRNA was then diluted 
to 50 ng/µL for oocyte injection. 
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2.4 Oocyte preparation 
 
Harvested Xenopus laevis oocytes were washed in four changes of ND96 saline 
(96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.4), de-
folliculated in ND96 saline with 1 mg/mL collagenase for approximately 2 h, 
washed again in four changes of saline, and then transferred to injection media 
(ND96 saline containing 2.5 mM Na-pyruvate, 0.66 mM theophyllen and 52 
µM of gentamycin). Healthy stage V-VI oocytes were selected and injected 
with 5 ng mRNA and injected oocytes were stored in ND96 saline at 17ºC in 
94 mm cell culture dishes (Greiner). Electrophysiological recordings were 
taken from oocytes ~24 h post-injection. 
 
2.5 Electrophysiological recordings 
 
Oocytes from the African clawed frog Xenopus laevis are a favoured 
heterologous expression system amongst electrophysiologists working on ion 
channels. Two-electrode voltage clamping (TEVC) of the oocyte allows any 
changes in current that result from an ion channel opening event to be recorded 
digitally and quantified. This technique allows the response following agonist 
application to be monitored, yielding quantitative results within real time.  
Conventional TEVC of Xenopus oocytes was performed using standard 
electrophysiological protocols. A GeneClamp 500B amplifier was connected to 
a PC running CLAMPEX v6.0.3 software via a DigiDate1200 Series Interface 
(all Axon Instruments, Molecular Devices UK). Glass microelectrodes were 
pulled from GC150TF-10 glass capillaries (Harvard apparatus) using a P-87 
micropipette puller (Sutter) to a resistance of 1-2 MΩ and back filled with 3 M 
KCl. 3 M KCl agar bridges connected ground electrodes to the bath (Fig. 2.1). 
Oocytes were held at a potential of -60 mV unless stated otherwise and 
perfused continuously with ND96 saline (recording saline) at a rate of 10-15 
mL/min. 
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GABA (Sigma) was diluted in recording saline and applied to the bath using a 
simple row of valve switches (See Fig. 2.1). Doses of GABA were applied 
successively to achieve a concentration-response curve.  
Concentration−response data were normalised to maximal current (IMAX) fitted 
to the four-parameter logistic equation using GraphPad PRISM version 4.03 for 
Windows (GraphPad USA, http://www.grphpad.com). Significance was 
calculated using a one-way ANOVA or an unpaired t-test (Prism v3.02). 
 
 
I = IMIN + (IMAX − IMIN)/[1 + 10
log(EC50−[A])
nH] 
 
Where IMAX = maximal response plateau 
IMIN = minimum response plateau 
[A] is the concentration of agonist, and  
nH is the Hill coefficient 
Four-parameter logistic equation 
Figure 2.1 Standard TEVC setup. Left: TEVC 
rig with gravity driven saline perfusion and drug 
valves for smooth saline/drug transitions (above). 
Oocyte is immobilised by a small piece of copper 
wire in the recording bath and impaled by 
borosilicate pipettes (below). Right: TEVC rig 
schematic 
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Automated TEVC was carried out using the MultichannelSystems© Robocyte 
R8 electrophysiology platform. This system allows pre-injected oocytes to be 
loaded individually into a 96-well plate with V-shaped wells (Greiner) for 
high-throughput automated recording. Supplier’s ready-made measuring heads 
were used; each head comprises two glass microelectrodes, two silver/silver 
chloride (Ag/AgCl) reference electrodes, and a perfusion inlet and outlet. 
Recording protocols can be defined in simple scripts – small text files written 
in the dedicated Roboocyte scripting language. Based on preselected 
parameters, the program decides whether a cell is suitable for further recording, 
and, if not, the Roboocyte simply proceeds to the next oocyte in the well plate 
to continue the measurements. The Robocyte system can thus operate 
continuously without any supervision until all tests are performed or all cells 
within the 96-well plate are tested. For a comprehensive review of the 
Robocyte system, see Leisgen et al. (2007). 
 
2.6 Sequence alignment 
 
The Drosophila melanogaster (GRBDROME) subunit was aligned with the 
sequence of the AChBP (primary accession number P58154) using FUGUE 
(Shi et al., 2001). FUGUE is an alignment program which assesses sequence 
similarity as well as quantifying this in the context of three-dimensional (3D) 
structure. FUGUE defines the conformation of the aligned protein considering 
main chain conformation, secondary structure, solvent accessibility and also H-
bonding. FUGUE considers the local environment to calculate the likelihood of 
amino-acid substitutions, insertions and deletions and uses this information to 
determine the scoring system of the alignment. 
 
2.7 Modelling 
 
A 3D model of the extracellular domain of the RDL receptor was created using 
MODELLER (Sali and Blundell, 1993), based on the AChBP (PDB accession 
number 1i9b) crystal structure. A dimer was generated by superimposing the 
modified monomer onto two protomers of the AChBP.  
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A model of the transmembrane regions of RDL was generated using the 
sequence of GLIC, a prokaryotic pentameric ligand-gated ion channel from 
Gloebacter violaceus (GLIC) (PDB ID: 3EAM). Homology models of mutant 
receptors were generated by the same method, by manually mutating the 
sequence of RDL before aligning using FUGUE.  
Models were analysed using RAMPAGE 
(http://raven.bioc.cam.ac.uk/rampage.php)(Lovell et al., 2003). Amino acids 
found in the unfavoured regions of this plot were visually inspected using 
ViewerLite (www.accelrys.com), to determine if their orientation will affect 
the binding site model.   
 
2.8 Ligand docking 
 
Binding site ligand structures generated using ChemBio3D Ultra 11.0 were 
energy minimised using the MM2 force field. Docking of the ligands into the 
RDL receptor homology model was carried out using GOLD 4.0. The binding 
site was defined using the αC atoms of the conserved aromatics F206, Y254 
and Y109, with a binding site radius of 10 Å. Ten genetic algorithm runs were 
performed on each docking exercise, giving a total of 10 solutions for each 
analogue. The structures were analysed using the implemented GoldScore 
fitness function to identify the most accurate simulation. Special attention was 
paid to GABA folding and conformation as well as positioning relative to 
conserved binding site residues and experimental evidence. Hydrogen bonding 
interactions between ligands and binding site residues were identified using the 
hydrogen bond monitor function in ViewerLite (www.accelrys.com). 
For channel-blocking antagonists, the PDB structures for ligands were 
downloaded from the CCDC (Cambridge Crystallographic Data Centre) 
database (http://www.ccdc.cam.ac.uk/). Compounds were docked into the 
homology model of the RDL transmembrane domain using the program GOLD 
4.0. Ten docking experiments were performed for each compound. 
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2.9 Quantum mechanical ab-initio calculations for ligands 
  
Molecular modelling was carried out with ChemBio3D Ultra 11.0 
(CambridgeSoft, UK; http://www.cambridgesoft.com). Ligand structures were 
generated in the charged zwitterionic state using the ChemDraw program. 
Ligands structures were energy minimized using the MM2 force field and 
Mulliken charges (partial atomic charges) were calculated using the GAMESS 
interface. Dipole distances were calculated using the atomic distance tool in 
ChemBio3D Ultra 11.0. 
 
  2.10 Site directed mutagenesis 
 
   2.10.1 Primer design 
Mutagenic primers containing the mutation and flanking complementary 
sequence were designed manually.  Primers were designed to be 25-45 bases in 
length with the mutation in middle with at least 10-15 bases either side. GC 
content was at least 40% and Tm was typically ~80°C. Primers were terminated 
with one or more C/G at either end. A local restriction site was also disrupted 
using a silent base substitution where applicable. Where no restriction sites 
could be removed a restriction site was inserted. This facilitates quick detection 
of mutant clones. All primers were obtained from Sigma-Aldrich. 
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Table 2.1 Oligonucleotide primers used 
Mutant Forward primer 
(5'->3') 
Reverse primer 
(5'->3') 
F206A GAAATCGAAAGTGGCGGTTACAC GTGTAACCGCCACTTTCGATTTC 
F206Y GAAATCGAAAGTTACGGTTACAC GTGTAACCGTAACTTTCGATTTC 
Y254F GGCAACTTTTCTCGTTAGCCTGC GCAGGCTAACGAGAAAAGTTGCC 
Y254A GGCAACGCTTCTCGTTTAGCCT AGGCTAAACGAGAAGCGTTGCC 
E204D GCCAGCTGTGCCACATTGAAATCGATAGCTTCGG CCGAAGCTATCGATTTCAATGTGGCACAGCTGGC 
E204A GCCAGCTGTGCCACATTGAAATCGCAAGCTTCGG CCGAAGCTTGCGATTTCAATGTGGCACAGCTGGC 
S205T GCCAGCTGTGCCACATTGAAATCGAAACCTTCGG CCGAAGGTTTCGATTTCAATGTGGCACAGCTGGC 
S205A GCCAGCTGTGCCACATTGAAATCGAAGCCTTCGG CCGAAGGCTTCGATTTCAATGTGGCACAGCTGGC 
Y208S GCCACATTGAAATCGAGAGCTTCGGTTCTACGATGCGAGATATCCG CGGATATCTCGCATCGTAGAACCGAAGCTCTCGATTTCAATGTGGC 
Y208F GAAAGTTTCGGTTTCACGATGCGA TCGCATCGTGAAACCGAAACTTTC 
R111A GGACTTCACATTGGATTTTTACTTTGCTCAGTTTTGGACCGATCC GGATCGGTCCAAAACTGAGCAAAGTAAAAATCCAATGTGAAGTCC 
R111K GGACTTCACATTGGATTTTTACTTTAAGCAGTTTTGGACCGATCC GGATCGGTCCAAAACTGCTTAAAGTAAAAATCCAATGTGAAGTCC 
Y109F GGACTTCACATTGGATTTTTTCTTTCGTCAGTTTTGGACCGATCC GGATCGGTCCAAAACTGACGAAAGAAAAAATCCAATGTGAAGTCC 
Y109S CACATTGGATTTTAGCTTTCGTCAGTTTTGG CCAAAACTGACGAAAGCTAAAATCCAATGTG 
Y109A GGACTTCACATTGGATTTTGCCTTTCGTCAGTTTTGGACCGATCC GGATCGGTCCAAAACTGACGAAAGGCAAAATCCAATGTGAAGTCC 
Y109R.R111Y GGACTTCACATTGGATTTTCGCTTTTATCAGTTTTGGACCGATCC GGATCGGTCCAAAACTGATAAAAGCGAAAATCCAATGTGAAGTCC 
S176T CGTAGTAAGACCTTGCTATTGTTC GAACAATAGCAAGGTCTTACTACG 
S176A CGTAGTAAGACCTCGCTATTGTTC GAACAATAGCGAGGTCTTACTACG 
A302S GCAACGCCGGCGCGTGTGTCGCTCGGTGTGACAAC GTTGTCACACCGAGCGACACACGCGCCGGCGTTGC 
T306S TGCAACGCCGGCGCGTGTGGCTCTCGGTGTGAGTACCGTGTTG TGGTCATTGTCAACACGGTACTCACACCGAGAGCCACACGCGC 
T306V TGCAACGCCGGCGCGTGTGGCTCTCGGTGTGGTAACCGTGTTG TGGTCATTGTCAACACGGTTACCACACCGAGAGCCACACGCGC 
L314Q GAC AAT GAC CAC TCA GAT GTC GTC AAC AAA TGC GAC AAT GAC CAC TCA GAT GTC GTC AAC AAA TGC 
R256A CCTAACCACAGGCAACTATTCGGCTTTAGCCTGCG CGCAGGCTAAAGCCGAATAGTTGCCTGTGGTTAGG 
R256K CCTAACCACAGGCAACTATTCGAAATTAGCCTGCG CGCAGGCTAATTTCGAATAGTTGCCTGTGGTTAGG 
T306V.A302S GGCGCGTGTGTCGCTCGGTGTGGTAACCGTGTTG CAACACGGTTACCACACCGAGCGACACACGCGCC 
 
   2.10.2 PCR 
Polymerase chain reaction (PCR) was carried out using a high-fidelity Pfu 
DNA polymerase (Stratagene) and mutagenesis reactions were made up in a 
1.5 mL Eppendorf tube as follows: 
 
 
    5 µL (10x) Buffer  
    1 µL Template DNA (100 ng) 
    1 µL (25 mM NTPs) (Stratagene) 
    3 µL Oligo (F) (150 ng) 
    3 µL Oligo (R) (150 ng) 
    32 µL dH20 
    5 µL DMSO* 
    1 µL Pfu  turbo 
    
    Covered with 50 µL mineral oil 
 
     *10% DMSO was added as it was found to greatly boost the PCR product 
 
 
PCR was carried out using standard protocol (QuikChange, Stratagene). 
Annealing temperatures were modified as required for successful incorporation 
of the mutation. A melting temperature of Tm Oligo - 5ºC was routinely used. 
This temperature was altered arbitrarily (± 5ºC) where reactions failed to 
produce a product. Dpn1 digestion (1 µL Dpn1 (NEB)/mutagenesis reaction) at 
 
  53 
37°C for 2 h was carried out to eliminate methylated template DNA from the 
PCR products. 1 µL of the reaction was run on a 1% agarose gel for 20 min to 
visualise any PCR product. 
 
 
Cycling Parameters 
95°C for 1 minute 
22 Cycles of:  1. 95°C for 1min 
2. 60°C for 1min  
3. 72°C for 10 min (or 2 min/kb DNA) 
72°C for 7min (extension time after cycles) 
  4°C for infinity 
 
 
    2.10.3 Preparation of electrocompetent E.coli  
A 3 mL culture of DH5α E.coli was grown over night in LB in an incubator 
shaker at 37ºC. A 300 mL flask of LB was inoculated with the 3 mL culture 
and was incubated at 37°C in incubator-shaker until the OD600 was 0.5. The 
culture was then chilled on ice for 15 min and then spun at 2,500 g (JA-14 
rotor) for 15 min at 4ºC. The supernatant was decanted and discarded and cells 
were rinsed in 300 mL ice cold dH2O. Cells were then re-spun as before and 
the supernatant discarded again. Cells were then rinsed in 100 mL ice cold 
dH2O, respun as before and then resuspended in 30 mL ice cold 10% glycerol 
and transferred to 50 mL Falcon tubes.  Cells were then spun at 2,500 g for 15 
min at 4ºC. Cells were finally resuspended in 2 mL 10% glycerol.  Aliquots of 
90 µL were pipetted into 1.5 mL Eppendorfs on dry ice.  Samples were stored 
at -80°C. 
 
    2.10.4 Transformation of DH5α cells 
45 µL of DH5α cells were electroporated (200 Ω, 1.8 kV, tau value 3 msec) 
with 1-7 µL mutagenesis reaction and 200 µL LB (at RT) was added 
immediately afterwards. The cell suspension was then incubated at 37°C for 1 
h. Cells were plated out on LB + amp (100 µg/mL) plates and placed in an 
incubator over night. 
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2.10.5 Plasmid minipreps and restriction digests  
Colonies from the transformed DH5α plate were selected and grown over night 
at 37°C in 2 mL LB + ampicillin (100 µg/mL) in an incubator shaker. Plasmid 
DNA samples were extracted (QIAGEN Miniprep) and 5 µL of DNA was used 
to set up restriction digest. Samples were then stored at –20°C. Restriction 
digests were set up in 1.5 mL Eppendorf tubes according to the table: 
 
Vector DNA 5 µL 
10X Buffer 1 µL 
Restriction enzyme 1 µL 
ddH2O 3 µL 
 
Digests were incubated for at least 1 hour at 37°C. Loading buffer, 5 µL, was 
added and samples were run on a 1% agarose gel with ethidium bromide added. 
Gels were viewed on a UV bed and photographs were taken. 
 
2.11 Assessment of antagonists using TEVC 
TEVC was performed using the method outlined in section 2.5. Oocytes 
showing steady GABA-evoked responses were selected before antagonists 
were applied. All recordings were carried out at EC50 concentrations of GABA. 
Antagonists were co-applied with GABA at a range of antagonist 
concentrations and responses were measured yielding IC50 values (the 
concentration of antagonist (M) at which half-maximal inhibition is achieved). 
 
2.12 Mutant cycle analysis 
 
Mutant cycle analysis can be used to investigate interactions between pairs of 
residues in proteins as well as interactions between residues and molecular 
groups on ligands (Hidalgo and MacKinnon, 1995). When assessing the effect 
of molecular groups on ligands the effect on ligand affinity of changing a 
ligand group or a protein residue, either individually or both together, is 
measured. If the individual effects are independent and additive, indicating no 
effective interaction between the two groups, then the coupling coefficient (Ω), 
defined in eqn. 1 below, will be equal to one. 
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The subscripts WT and MUT represent the wild type and mutant receptor, 
respectively, and L1 and L2 denote the two ligands being compared. Values of 
Ω > 2.5 have been shown to identify direct interactions between molecular 
groups (Schreiber and Fersht, 1995). The interaction energy, ∆∆Gint, between 
the two substituted groups is given by RTlnΩ, where R is the gas constant 
(8.314 JK-1M-1) and T is temperature (293 K). Ω values < 1 were normalised by 
the function Ω-1.  
 
2.13 Whole insect Bioassays 
 
Bioassays were carried out by Mirel Puinean and Martin Williamson at 
Rothamsted Research, Hertfordshire. N.lugens, the brown planthopper was 
chosen as it is a typical crop pest. Adult brachypterous (short-winged) 
susceptible females were used to assess responses to compounds. Bioassays 
consisted of 3 replicates per dose, each one with 10-20 individual insects. 
Insects were removed directly from rearing cages, lightly anaesthetised with 
CO2 and dosed on the prothorax using 0.25 µL of acetone as the solvent carrier. 
Endpoint readings were taken at 48 h. Bioassays for 50 ppm and 1000 ppm 
were carried out. 
 
2.14 Culture of HEK293 cells 
 
Human embryonic kidney (HEK) 293 cells were maintained on 90 mm tissue 
culture plates at 37 °C and 7% CO2 in a humidified atmosphere. They were 
cultured in DMEM: F12 (Dulbecco's Modified Eagle Medium/Nutrient Mix 
F12 (1:1)) with Glutamax I™ containing 10% foetal calf serum and passaged 
when confluent. 
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2.15 FlexStation recording  
 
 2.15.1 HEK293 transfection  
 
Cells were stably transfected with pcDNA3.1 (Gibco: Invitrogen) containing 
the complete coding sequences for the human 5-HT3A receptor subunit 
(Genbank accession number P46098), as previously described (Hargreaves et 
al., 1996). For heteromeric receptors, approx 106 HEK293 cells (stably 
expressing human 5-HT3A receptors) were transfected (electroporation: 1300 
V, 30 ms) with 5 µg of human 5-HT3B subunit DNA (Genbank accession 
number O95264; pcDNA3.1, Invitrogen) using the microporator system 
(DigitalBio, Labtech), as per manufacturer’s instructions. Cells were then 
plated (approximately 3 × 104 cells/well) onto black sided, clear bottomed, 96 
well plates (Greiner) for FlexStation assays. Cells were incubated 1–2 days 
before assay. 
 
 2.15.2 Recording 
HEK293 cells in each well were briefly washed once with 100 µL flex buffer 
(115 mM NaCl, 1 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM glucose, 
10 mM HEPES pH 7.4) at room temperature, and then incubated for 1 h at 
37 °C in 100 µL flex buffer containing 1% v/v membrane potential dye 
(Reagent A-Blue Kit, Labtech). Fluorescence was measured every 2 s for 200 s 
and, at 20 s, 50 µL of agonist or flex buffer was added to each well. Softmax 
Pro (Molecular Devices, UK) or Prism (GraphPad, USA) was used for data 
analysis. The percent change in fluorescence, which was calculated as F (peak 
fluorescence) minus F0 (baseline fluorescence at 20 s) divided by agonist Fmax 
(peak fluorescence), and was compared across agonist concentrations yielding 
data points to be plotted as a concentration-response curve. 
2.16 Single-channel electrophysiology  
HEK293 cells were transfected with subunit cDNA for human 5-HT3A and 5-
HT3B subunits (pcDNA3.1, Invitrogen) using calcium phosphate precipitation 
as previously described (Corradi et al., 2009). For a 35 mm dish of cells, the 
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total amount of cDNA was 5 µg, and the ratio of A to B subunit cDNA was 1:5. 
Single-channel recordings were obtained from HEK293 cells one or two days 
after transfection in the cell-attached configuration (Corradi et al., 2009; 
Hamill et al., 1981) at a membrane potential of -70 mV, -100 mV and -120 mV 
at 20°C. The bath and pipette solutions contained 142 mM KCl, 5.4 mM NaCl, 
0.2 mM CaCl2, and 10 mM HEPES, pH 7.4. Solutions free of magnesium and 
with low-calcium were used to minimize channel block by divalent cations. 
Patch pipettes were pulled from 7052 capillary tubes (Garner Glass) and coated 
with Sylgard (Dow Corning). Pipette resistances ranged from 5 to 7 MΩ. 5-HT 
was added to the pipette solution at roughly EC50 concentration. 
Single-channel currents were recorded using an Axopatch 200 B patch-clamp 
amplifier (Molecular Devices, US), digitized at 5 µs intervals with the PCI-
6111E interface (National Instruments), recorded to the computer hard disk 
using the program Acquire (Bruxton Corporation), and detected by the half-
amplitude threshold criterion using the program TAC 4.0.10 (Bruxton 
Corporation) at a final bandwidth of 10 kHz (Gaussian digital filter).  
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Chapter 3 
 
Biophysical properties of RDL receptors 
______________________________________________ 
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Introduction 
 
 
3.1 Introduction 
 
Oocytes from the African clawed frog, Xenopus laevis, are a favoured 
heterologous expression system amongst electrophysiologists working on ion 
channels. Two-electrode voltage clamping (TEVC) of the oocyte allows any 
changes in current that result from an ion channel opening event to be observed 
and quantified. This technique allows the response following agonist 
application to be monitored, yielding quantitative results within real time. 
Responses for a range of agonist concentrations can be recorded from the same 
oocyte, allowing concentration-response curves to be generated, yielding an 
EC50 value for the agonist. Here I determine the EC50 value for GABA at RDL 
receptors using conventional TEVC as well as the automated Robocyte R8 
system.  
 
By measuring the amplitude of maximal currents elicited from oocytes 
expressing RDL receptors over a time course, we can determine the optimum 
incubation time for conducting electrophysiological experiments. Here I 
measure the maximal currents over a 72 hour period post-injection. 
 
RDL receptors are GABA-activated chloride channels. Allowing the passage of 
anions into the cell allows the generation of IPSPs, facilitating inhibitory 
neurotransmission under normal physiological conditions. By reducing the 
chloride concentration in the extracellular saline, changes in the reversal 
potential for the receptor can be used to determine the charge selectivity of the 
channel pore. This strategy has been employed in determining the charge 
selectivity of the acetylcholine receptor (Galzi et al., 1992). Here I have 
reduced the chloride concentration in the extracellular saline by 90%, 
substituting chloride ions with the large isethionate anion, to determine the 
effect of chloride concentration on channel currents. 
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Changes in the extracellular pH have been shown to affect the maximal 
currents of GABAA receptors in a subunit dependant manner (Krishek et al., 
1996a). Here I investigate the effect of a change of pH on RDL receptors 
currents. 
 
The aims of this chapter were to characterise the biophysical properties of RDL 
GABA receptors expressed in Xenopus oocytes, specifically determining the 
GABA EC50 value, the expression rate, the ionic selectivity of the channel pore 
and the sensitivity of the receptor to changes in pH. 
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Results 
 
 
3.2 Results 
 
In order to test RDL receptor function in Xenopus oocytes, the rdl gene was 
subcloned from pcDNA3.1 into the oocyte expression vector pGEMHE. The 
rdl gene was excised from pcDNA3.1 using the restriction enzymes AflII and 
XbaI (Fig. 3.1) and cloned into pGEMHE using the same restriction sites. 
 
 
Figure 3.1 AflII XbaI excision of rdl from pcDNA3.1. 
 
 
3.2.1 Expression of RDL receptors in Xenopus oocytes 
 
Application of GABA to Xenopus oocytes expressing RDL receptors elicited 
concentration-dependant inward currents (Fig. 3.2). Little desensitisation 
occurred when GABA was applied successively to an oocyte expressing RDL 
receptors. RDL receptors recovered quickly following withdrawal of agonist 
allowing successive applications of agonist to be applied generating a 
concentration-response course. Plotting current amplitude against a range of 
GABA concentrations revealed an EC50 of ~20 µM (Fig. 3.3) which is similar 
to previously published results  (10-31 µM) (Belelli et al., 1996; Hosie et al., 
2001; Hosie and Sattelle, 1996a; McGurk et al., 1998). The dose response 
profiles as yielded by the automated Roboocyte R8 system and by conventional 
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TEVC are identical, giving confidence that an accurate EC50 value has been 
arrived at (Table 3.1). 
 
Although the Robocyte system allows accurate and reliable measurements of 
receptor function, it was felt that conventional TEVC allows more user control 
and adaptability. For cases where oocyte health varies or where immediate 
control of drug/wash is required, conventional TEVC affords the user greater 
control to quickly alter the recording protocol. For these reasons, unless 
otherwise stated, all further experiments in this dissertation were carried out 
using conventional TEVC. 
 
 
Figure 3.2 Electrophysiological traces from wild-type RDL receptors expressed in 
Xenopus laevis oocytes using conventional TEVC. Inward currents are evoked when GABA 
is applied. A range of doses of GABA were applied yielding data to plot a concentration-
response curve.  
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Figure 3.3 Concentration-response curves for RDL receptors expressed in Xenopus 
oocytes for both the automated electrophysiology system (Robocyte R8) and conventional 
TEVC. The concentration-response curves for the automated system (Robocyte R8) and 
conventional TEVC are similar. 
 
Table 3.1 Parameters derived from concentration-response curves. 
Recording system pEC50 ± SEM EC50 (µM) nH  ± SEM n 
Robocyte R8 4.671 ± 0.042 21.3 1.8 ± 0.3 6 
TEVC 4.705 ± 0.039 19.7 1.8 ± 0.2 19 
 
Data = mean ± SEM, nH is the Hill coefficient, n indicates number of replicates. Data are not 
significantly different (p=0.93, Student’s t-test). 
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3.2.2 RDL expression rate  
 
To determine the stability of receptor expression and to detect any decay of 
current amplitude occurs, EC50 currents were measured over a twenty minute 
period, a time scale representative of a typical experiment on a single oocyte. 
No decrease in current amplitude was detected over twenty minutes, 
confirming that receptors express stably (Fig. 3.4). 
 
 
 
 
Figure 3.4 EC50 current amplitudes from RDL receptors expressed in Xenopus oocytes 
over 20 min. RDL EC50 currents do not decay over a 20 min period as demonstrated by 
sample electrophysiological traces (above) and a graph of mean currents (± SEM) (n≥5 
oocytes). 
 
 
RDL receptor maximal currents (evoked by 100 µM GABA) were recorded 
over a 72 hour period (post injection of cRNA) to determine expression rate in 
Xenopus oocytes. No response was observed at 6 h. At 60 hours no currents 
could be recorded and the oocytes health had deteriorated with a high 
membrane leak (>200 nA). Maximal currents (~7 µA) were observed at 40 h 
(Fig. 3.5). 
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Figure 3.5 Maximal currents from RDL receptors expressed in Xenopus oocytes over 72 
h. A Sample current traces for 100 µM GABA (IMax) at 6 h, 24 h, 30 h and 48 h. B Maximal 
current amplitudes over 72 h (n≥6 oocytes for each data point). 
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3.2.3 Ionic selectivity of RDL receptors 
 
Maximal GABA currents were recorded over a range of voltages, in both 
standard ND96 saline (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, 5 mM HEPES, 
pH 7.4), as well as a low chloride substitute (6 mM NaCl, 2 mM KCl, 1 mM 
MgCl2, 5 mM HEPES, 90 mM Na-Isethionate, pH 7.4). 
Reducing the chloride concentration resulted in an increase in the voltage 
reversal potential as evinced by a shift to a higher voltage of the IV curve, as 
characteristic for a chloride selective channel (Fig. 3.6). Published values for 
the internal ion concentrations for the Xenopus oocyte are: [K+], [Na+] and [Cl-
]; 110, 10 and 38 mM respectively (Costa et al., 1989). Since the internal 
chloride concentration of the Xenopus oocyte has been determined to be close 
to 40 mM (Costa et al., 1989), we can use the Goldman-Hodgkin-Katz 
Equation (Fig. 3.6) to determine the relative permeability of cations and anions 
through the channel pore.  
 
 
Figure 3.6 The Goldman-Hodgkin-Katz Equation. Vm is the membrane reversal potential. 
R is the universal gas constant (8.314 J.K-1.mol-1), T is the temperature in Kelvin (°K = °C + 
273.15), F is the Faraday's constant (96485 C.mol-1), pK is the membrane permeability for K
+, 
pNa is the relative membrane permeability for Na
+, pCl is the relative membrane permeability 
for Cl-, [K]o is the concentration of K
+ in the extracellular fluid, [K]i is the concentration of 
K+ in the intracellular fluid, [Na]o is the concentration of Na
+ in the extracellular fluid, [Na]i 
is the concentration of Na+ in the intracellular fluid, [Cl]o is the concentration of Cl
- in the 
extracellular fluid and [Cl]i is the concentration of Cl
- in the intracellular fluid.  
 
A reversal potential of -22.2 mV was determined for receptors in ND96 saline 
and +11.2 mV in low chloride (10 mM) saline (Fig. 3.7). Such an increase in 
the reversal potential is characteristic of a chloride selective channel as shown 
by the Goldman-Hodgkin-Katz Equation rationale. Taking the combined 
extracellular concentrations of potassium and sodium together the relative 
permeability of cations to anions was calculated for both experiments. The 
 
  67 
relative permeability of cations and anions was determined to be 0.07:1 and 
0.26:1 in ND96 and low chloride saline respectively. 
 
Figure 3.7 Voltage-reversal experiments for RDL receptors in ND96 and low chloride 
saline. Above: Sample current traces for RDL receptors (maximal currents [GABA] = 100 
µM) in normal ND96 and low chloride (10 mM) saline. Below: IV curves for normal and low 
chloride saline. Data = mean ± SEM for at least four oocytes. An increase in the reversal 
potential as shown with the reduced chloride saline is characteristic of a chloride selective 
channel. Reversals potentials were significantly different (p=0.03, paired t-test) and slopes 
were not significantly different (p=0.16, paired t-test). 
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3.2.4 pH sensitivity of RDL receptors 
 
Since GABA itself is an acid I felt it important to assess the affect of GABA on 
the pH of a solution and to determine if perturbations in pH have an affect on 
receptor function.  
The concentration-pH relationship for GABA in aqueous solution was 
determined using the program ChemBuddy (www.chembuddy.com) (Fig. 3.8). 
RDL receptors reach maximal activation at 100 µM GABA. At this 
concentration of GABA the pH of an unbuffered aqueous solution is 4.2. If 
high concentrations of GABA were to be reached in the synaptic cleft or the 
extrasynaptic milieu, local pH perturbations may play a role in modulating 
receptor function. Solutions of GABA in buffered recording saline (pH 7.4) 
were tested for changes in pH with the addition of GABA. Concentrations as 
high as 1 mM GABA effected no change in the pH of the saline. 
 
Figure 3.8 pH of an aqueous solution of GABA. Concentration-pH relationship for GABA 
(pKa 4.03 (Huxtable et al, 1987)) in aqueous solution. Generated using the ChemBuddy 
program (www.chembuddy.com).  
 
The effect of ten and one hundred-fold changes in extracellular pH on RDL 
receptor function was determined. An increase in the extracellular pH to 8.5 
and 9.5 caused a decrease in the EC50 current of approximately 10% and 20% 
respectively. A decrease in the pH to 6.5 and 5.5 caused no decrease in the 
EC50 current (Fig. 3.9). 
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pH mean 
current 
SEM n 
5.500 0.915 0.024 6 
6.500 0.909 0.028 7 
7.500 1.000 0.000 6 
8.500* 0.881 0.038 8 
9.500* 0.786 0.031 6 
 
Figure 3.9 The effect of a pH change on the current amplitude of RDL receptors. Above: 
Sample traces showing the effect of a change in pH during a non-desensitising EC50 response. 
Changing the pH to 9.5 during the course of the receptor response decreased the current 
amplitude within ten seconds, whilst a decrease in pH to 5.5 had no effect. Below The effect 
of a change in pH upon GABA EC50 currents. Data = mean ± SEM for at least six oocytes. 
Currents at pH 5.5 and 6.5 are not significantly different from pH 7.5 (p>0.05, t-test).  
* denotes currents at pH 9.5 and 8.5 are significantly different from pH 7.5 (p<0.05, t-test). 
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Discussion 
 
3.3  Discussion 
 
In this chapter I have assessed the biophysical properties of RDL receptors 
expressed in Xenopus oocytes. I have determined the GABA EC50 and I have 
assessed the rate at which the oocyte expresses RDL receptors. I have 
demonstrated the anionic selectivity of RDL receptors and I have also assessed 
the sensitivity of these receptors to changes in extracellular pH. 
 
The RDL subunit, an insect GABAA –like receptor, can be expressed readily in 
the Xenopus oocyte expression system. Maximal current responses were 
detected ~40 h post-injection. To facilitate experiments it was deemed optimal 
to inject in the morning and to record responses the following day, i.e. 24 h 
later, thus utilising the greatest window of opportunity for measuring robust 
current responses.  
The MultichannelSystems© Robocyte R8 automated TEVC electrophysiology 
platform yielded an EC50 value not significantly different to those arrived at 
using conventional TEVC. The GABA EC50 value is in line with previously 
published values (Hosie et al., 2001; Hosie and Sattelle, 1996a). This makes 
the Robocyte R8 a useful and reliable tool for studying ligand-gated ion 
channels. 
 
Cys-loop receptors elicit a cellular response by allowing the passage of cations 
or anions either into or out of the cell in an agonist dependant manner. The 
selectivity of the channel to cations/anions determines whether the effect of 
channel opening will lead to EPSPs or IPSPs, respectively. The ion selectivity 
filter is located close to the second transmembrane region of the receptor and 
residues that line the pore have been indentified to be responsible for charge 
selectivity in these receptors (Galzi et al., 1992; Gunthorpe and Lummis, 2001; 
Keramidas et al., 2000; Thompson and Lummis, 2003) (Fig. 3.10). 
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SFWINMDAAPARVGLGITTVLTMTTQSSGSRA 
SFWLNRESVPARTVFGVTTVLTMTTLSISARN 
GFYLPPNSG-ERVSFKITLLLGYSVFLIIVSD 
VFLLPADSG-EKISLGITVLLSLTVFMLLVAE                                               
SFWLNRNATPARVALGVTTVLTMTTLMSSTNA 
 * :  ::   :  : :* :*  :.                  
 
Figure 3.10 Alignment of M2 regions of RDL and other Cys-loop receptors. The -1' 
residue (highlighted) has been shown to be responsible for ionic selectivity in the 5-HT3A 
receptor (Gunthorpe and Lummis, 2001; Thompson and Lummis, 2003), the nAChR (Galzi et 
al., 1992) and the glycine receptor (Keramidas et al., 2000). RDL, like the glycine and 
GABAA receptors, has an alanine residue at the -1' position suggesting that the channel is also 
anion selective.  
 
RDL receptors are similar to other anionic selective channels, with neutral 
residues at the -1' position, and the findings here show that the channel is 
indeed selective for anions. My results here show that the channel is 
predominantly anion selective and that at low chloride levels, cations may 
compete for passage through the channel pore. A mutagenesis study of the β 
subunit of GABAA  receptors has shown that mutating the residues at positions 
-5' to 0' to those of the α7 nicotinic acetylcholine receptor subunit converts the 
channel from being anion selective to cation selective (Jensen et al., 2002). 
This study fits with other work which showed that the ionic selectivity filter 
lies in the M1-M2 cytoplasmic loop of acetylcholine receptors (Wilson and 
Karlin, 2001; 1998). Similar studies on the 5-HT3R have highlighted the 
critical role of the -1' residue (Gunthorpe and Lummis, 2001; Thompson and 
Lummis, 2003) and proximal mutations (0, -1' and -2' residues) have been 
shown to convert GlyRs from anionic to cationic selective (Keramidas et al., 
2000), with the converse mutations rendering the acetylcholine receptor anion 
selective (Galzi et al., 1992). Given the critical role of this region in 
determining the ionic selectivity of Cys-loop receptors, it is unsurprising that 
                         M2 
                                          ___________________ 
                               -11'                   -4'          0'                  6'                12'                       20' 
Glycine α1 
GABA α1 
5-HT3A      
AChRα7 
RDL 
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RDL receptors are anion selective, given their similarity to their vertebrate 
orthologues. 
Changes in external pH are a feature of certain pathological processes such as 
ischaemia, anoxia and epileptiform activity (Chen and Chesler, 1992; Chesler, 
1990; Kraig et al., 1983; Urbanics et al., 1978) and therefore inhibitory 
neurotransmission may be affected by such biophysical perturbations. 
Additionally, activation of GABAA receptors may change the external pH 
following bicarbonate efflux through the integral anion selective channel 
(Kaila, 1994; Kaila and Voipio, 1987) and this phenomenon could lead to 
physiological changes in GABA signalling. Indeed α1β1 GABAA receptors 
EC50 currents are potentiated by lowering the pH of the external medium from 
7.4 to 5.4 by (73 ± 10%, mean ± SEM). In contrast, increasing the pH from 7.4 
to 9.4 resulted in a reduction (36 ± 11%) in the response to GABA (Wilkins et 
al., 2005). While an increase in pH has been shown previously to have little or 
no affect on GABAAR currents (Huang et al., 1999; Krishek et al., 1996a), 
Wilkins et al. (2005) showed that GABA-activated currents are potentiated at 
pH 8.4 for both αβ and αβγ subunit-containing receptors, but only at GABA 
concentrations below the EC40. This same study also identified a critical role of 
the 24' lysine residue in the M2-M3 extracellular linker in the modulation of 
GABA currents. A prior study of GABA receptors has shown that this pH 
modulation is subunit dependent (Krishek et al., 1996a), with a histidine 
residue at the 17' position in the β subunit being critical to modulation at low 
pH (Wilkins et al., 2002). The homologous residue in RDL is different (17'S) 
while the 24' residue is conserved (24'K) so it is possible that the protonation 
state of this residue could affect channel gating. However, RDL receptors 
displayed relative resistance to changes in extracellular pH when compared to 
their vertebrate orthologues, with no potentiation observed at higher or lower 
pH. In fact current reduction was observed at higher pH (pH 8.5 and 9.5) with 
no change at lower pH (pH 6.5 and 5.5), distinguishing RDL receptors from 
GABAA receptors. These results demonstrate that a large change in pH has only 
a small effect on RDL receptor function and this finding may have wider 
implications for insect physiology and neural signalling. 
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Conclusion 
 
3.4 Conclusions 
 
RDL receptors express stably in Xenopus oocytes with large currents (~ 5 µA) 
detectable at ~30 h. The Robocyte R8 is an effective automated 
electrophysiology platform for testing Cys-loop receptor function, post mRNA 
injection, and it is a reliable accompaniment to standard TEVC, yielding 
identical EC50 values. RDL receptors are predominantly chloride selective ion 
channels, highlighting their important role in inhibitory neurotransmission. 
RDL receptors are resistant to changes in extracellular pH, with only moderate 
effects at pH 8.5 and pH 9.5. These findings provide a biophysical profile for 
the functioning of RDL receptors, showing their agonist sensitivity, ionic 
selectivity and insensitivity to pH modulation. These findings may contain 
useful information for further studies on the physiological properties of insect 
GABA receptors. 
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Chapter 4 
 
Molecular characterisation of agonists that bind to 
RDL receptors 
______________________________________________ 
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Introduction 
 
 
4.1 Introduction  
 
Cys-loop receptors, such as GABAA, GABAC (a subclass of GABAA), glycine, 
5-HT3, and nicotinic acetylcholine (nACh) receptors, have homologous regions 
which form their agonist binding sites. These are located in the extracellular 
domain and are comprised of six discontinuous loops, named A-F (See Fig. 
1.12).  There are as yet no high resolution structural data of a complete 
vertebrate Cys-loop receptor, but the lower resolution nACh receptor structure, 
and homologous structures, such as those from the related acetylcholine 
binding protein (AChBP), have been useful for creating homology models 
(Brejc et al., 2001; Miyazawa et al., 2003; Sixma et al., 2003; Unwin et al., 
2002). Homology models have been created for many different vertebrate Cys-
loop receptors including nACh, 5-HT3, GABA and glycine receptors (Bartos et 
al., 2009b; Padgett et al., 2007; Pless et al., 2008; Thompson et al., 2008), but 
invertebrate Cys-loop receptors have been largely ignored.  The lack of models 
for these proteins is surprising, as these proteins are the targets of a number of 
invertebrate specific ligands, such as insecticides, and a better understanding of 
critical binding site features could assist the development of novel, more 
effective compounds (Casida, 1993; 2009). Some information, however, can be 
extrapolated from vertebrate models, which supports previous mutagenesis and 
labelling studies in showing that aromatic residues in the binding loops 
contribute to the formation of an “aromatic box” that is important for ligand 
binding in all of these receptors (Beene et al., 2002; Beene et al., 2004; 
Harrison and Lummis, 2006; Padgett et al., 2007; Pless et al., 2007). However, 
critical residues are not necessarily equivalent for different receptors; even in 
the closely related GABAA and GABAC receptors, for example, GABA has 
different orientations in the binding pocket: in the former there is a cation-π 
interaction between GABA and a tyrosine residue in loop A, while in the latter 
this interaction is with a tyrosine in loop B (Lummis et al., 2005b; Padgett et 
al., 2007). Nevertheless, in both these receptors, there is evidence that the 
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carboxylate residue is close to arginine residues in loop D (Harrison and 
Lummis, 2006; Wagner et al., 2004), suggesting that GABA has broadly 
similar orientations in both GABA receptor binding sites.  
There are a range of invertebrate Cys-loop receptors that are activated by 
GABA, but, as mentioned above, we know little about the molecular details of 
insect GABA receptor binding sites. The aim of this study was to identify the 
molecular determinants of agonist binding and potential interactions with 
binding site residues in RDL receptors, one of the best studied classes of insect 
GABA receptor.  
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Results 
 
4.2 Results 
4.2.1 Functional responses:  
 
A range of GABA analogues was tested for activity at RDL receptors (Fig. 
4.1). The most potent of these were muscimol, TACA and isoguvacine (Table 
4.1; Fig. 4.2). THIP and β-alanine are weaker agonists with EC50 s of 220 and 
800 µM respectively, while 5-aminovaleric acid (5-AV) and taurine were very 
weak agonists with EC50 values of 1.1 mM and > 10 mM respectively. GHB, a 
GABAB receptor agonist, and 3-APP, a GABAC and GABAB receptor 
antagonist, had no activating effect at RDL receptors. Glycine, 4-AB, PABA, 
and tyramine also failed to activate RDL receptors when applied at 
concentrations up to 10 mM. EC50 values for previously tested analogues 
(muscimol, β-alanine, TACA and isoguvacine) are close to published values 
(Hosie and Sattelle, 1996a). None of the compounds tested were antagonists of 
RDL receptors. 
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Figure 4.1 Chemical structures of GABA analogues examined in this study. Taken from 
McGonigle and Lummis, 2010, with copyright permission from ACS Biochemistry. 
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Figure 4.2. A. Electrophysiological traces showing maximal currents elicited by agonists 
tested at RDL receptors; GABA (100µM), TACA (300 µM), Isoguvacine (600 µM), β-
alanine (10 mM) and Taurine (10 mM). B. Concentration-response curves showing the 
relative potencies of GABA and GABA analogues at wild-type RDL receptors expressed in 
Xenopus oocytes. EC50 values for analogues tested:  Muscimol < GABA < TACA < 
isoguvacine < THIP < 5-AV < β-alanine < taurine. Data represent mean ± SEM,  n > 3. Taken 
from McGonigle and Lummis, 2010, with copyright permission from ACS Biochemistry. 
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Table 4.1 Parameters derived from concentration-response curves. 
Agonist
  
pEC50 ± SEM EC50 
(µM) 
nH ± SEM n IMax/IMaxGABA 
Muscimol 5.044 ± 0.04 9.04 2.2 ± 0.6 5 0.87 ± 0.03 
GABA 4.705 ± 0.04 19.7 1.8 ± 0.2 19   1.0 ± 0.06 
TACA 4.435 ± 0.02 36.7 1.8 ± 0.2 3   1.0 ± 0.02 
Isoguvacine 4.188 ± 0.03 64.9 1.9 ± 0.2 5 0.97 ± 0.03 
THIP 3.645 ± 0.10 226 2.4 ± 1.0 5 0.57 ± 0.06 
β-alanine 3.096 ± 0.03 801 2.0 ± 0.3 10   1.0 ± 0.03 
5-AV 2.950 ± 0.15 1120 1.0 ± 0.3 4 0.85 ± 0.1 
Taurine < 2.0 > 10,000 - 3 - 
GHB N/R - - - - 
3-APP  N/R - - - - 
Glycine N/R - - - - 
4-AB N/R - - - - 
PABA N/R - - - - 
Tyramine N/R - - - - 
Data = mean ± SEM; N/R indicates no response, nH is the Hill coefficient, n indicates number 
of replicates. IMax/IMaxGABA indicates the maximal response compared to GABA. Taken 
from McGonigle and Lummis, 2010, with copyright permission from ACS Biochemistry. 
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4.2.2 Computational ligand analysis  
 
The atomic distance between the ammonium nitrogen and the carboxylate 
oxygen, or its equivalent substituent, was calculated for all ligands tested. 
Comparing these data to the ligand EC50 values (Table 4.2) indicates that the 
most potent activators have a dipole separation distance of ~5 Å. Glycine has a 
dipole separation distance of 2.35 Å, and may be too short to activate RDL 
receptors, while for tyramine the distance was 7.94 Å, thus this molecule may 
be too long to fit into the binding site cleft. GHB and 3-APP, however, which 
have dipole separation distances of 5.1 Å and 4.5 Å respectively, are not 
agonists, while 5-AV, which has a dipole separation distance of 6.5 Å, can 
activate receptors. These data suggest that other factors also play a role.  One of 
these may be charge distribution; partial atomic charge calculations suggest 
there is a dependence on the electrostatic potentials of atomic groups at either 
end of the ligand. Partial atomic charges of + 0.3 at ammonium hydrogen 
atoms and - 0.5 to - 0.6 on carboxylate oxygen atoms were common amongst 
the most potent ligands (Table 4.2). However for 3-APP and 4-amino-1-butanol 
(4-AB), which do not activate receptors, the charges on phosphonic acid and 
hydroxyl oxygens are -1.2 and - 0.4 respectively. Additionally, 4-AB and GHB 
are not zwitterions and thus carry no formal charge, and so even if their length 
is close to optimal for receptor activation, their inactivity could be attributed to 
the absence of charge at either end of the ligand. The hydroxyl of GHB cannot 
substitute the ammonium of GABA, confirming the importance of this group 
for ligand binding at RDL receptors.  
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Table 4.2 Dipole separation distances of GABA analogues. 
 
Ligand Potency  
pEC50 
Dipole 
separation 
 (Å) 
Carboxylate Oxygens* Ammonium 
Hydrogens 
Muscimol 5.04 5.22 -0.26 (Isox-N),  -0.47 0.32, 0.32, 0.30 
GABA 4.71 4.83 -0.60, -0.54 0.31, 0.31, 0.29 
TACA 4.44 4.88 -0.57, -0.53 0.31, 0.31, 0.29 
Isoguvacine 4.19 4.86 -0.55,  -0.53 0.29, 0.31, 0.29 
THIP 3.65 5.14 -0.25 (Isox-N), -0.46 0.29, 0.31, 0.31 
β-alanine 3.09 4.37 -0.58,  -0.51 0.29, 0.29, 0.29 
5-AV 3.06 6.47 -0.61, -0.56 0.31, 0.31, 0.30 
Taurine < 2.0 4.46 -1.11, -1.12 0.30, 0.30, 0.28 
GHB N/R 5.10 -0.61, -0.61 -0.38 (Hydroxyl-O) † 
3-APP N/R 4.50 -1.23, -1.23 (Phos-O) 0.29, 0.31,  0.31 
Glycine N/R 2.35 -0.47, -0.57 0.32,  0.32, 0.27 
4-AB N/R 6.20 -0.38 (Hydroxyl-O) 0.19, 0.20, 0.24 
PABA N/R 6.39 -0.54, -0.54 0.30, 0.30, 0.30 
Tyramine N/R 7.94 -0.47 (Hydroxyl-O)  0.31, 0.30, 0.30 
 
Mulliken charges of GABA analogues calculated using the GAMESS interface. Ammonium 
hydrogens and carboxylate oxygens, or their equivalent substituents for the dipole, are listed. 
*Ligands without carboxyl groups were assessed by their equivalent groups: Isoxazole 
nitrogens in THIP and muscimol, phosphate oxygen in 3-APP, and hydroxyl oxygen in 4-AB 
and tyramine. † GHB does not have an ammonium group. The charge on the hydroxyl oxygen 
is negative. Taken from McGonigle and Lummis, 2010, with copyright permission from ACS 
Biochemistry. 
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4.2.3 Homology modelling and docking 
 
Homology modelling of the extracellular domain of RDL was based on the 
crystal structure of AChBP and analogue docking was ranked based on the 
GOLDscore fitness function, which ranks simulations by comparing interaction 
energies by consideration of predicted protein-ligand hydrogen bond energy, 
protein-ligand van der Waals energy, ligand internal van der Waals energy and 
ligand torsional strain energy, and has been established as an accurate method 
for scoring ligand-protein docking (Verdonk et al., 2003). The most favored 
orientation for GABA in the binding site was with the ligand in the cleft 
between loops B, C, and D (Fig. 4.3). The carboxyl group of GABA was 
deepest in the cleft, located close to residues Y109 and R111 in loop D. The 
ammonium was located between aromatic residues contributed by loop B 
(F206) and loop C (Y254), suggesting a cation-π interaction with one or both of 
these residues.  A hydrogen bond was predicted between the ammonium of 
GABA and the backbone carbonyl of S205.  5-AV docked in a similar 
orientation with a hydrogen bond predicted at the same location. β-alanine was 
found to dock in two almost equally favored orientations. One of these was 
similar to the orientation of GABA described above, with the carboxyl deep in 
the cleft and the ammonium sandwiched between F206 and Y254. In this 
orientation there was a hydrogen bond between the ligand ammonium and the 
S205 backbone carbonyl oxygen. In the second orientation β–alanine was close 
to S131 above loop E, and there was a hydrogen bond between the ligand 
ammonium and the side chain hydroxyl. 
All other agonists docked with the ammonium moiety oriented close to loop B 
residues E204 and S205, with hydrogen bonds predicted between these 
residues and TACA and taurine (Table 4.3).  Muscimol and isoguvacine were 
predicted to hydrogen bond with residues L249 and Y254 respectively. These 
orientations also position their carboxylate moieties close to loop D residue 
R111.  
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Table 4.3 Hydrogen bonding partner residues predicted from docking of functional 
GABA analogues. 
Analogue H-bonding 
residues predicted 
GABA S205 
β-alanine S205 
5-AV S205 
Muscimol L249 
Isoguvacine Y254 
TACA S205, E204 
Taurine S205, E204 
THIP None detected 
Taken from McGonigle and Lummis, 2010, with copyright permission from ACS 
Biochemistry. 
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Figure 4.3 Docking of GABA and active analogues (β-alanine, TACA, 5-AV, taurine, 
isoguvacine, muscimol and THIP) into the RDL binding site. Analogues docked with the 
ammonium group located deep in the cleft formed between loop B and loop C aromatic 
residues. The carboxylate moiety or equivalent substituent was predicted to be located facing 
towards R111. Atomic colour scheme: Grey (Carbon); Red (Oxygen); Blue (Nitrogen); White 
(Hydrogen); Orange (Sulphur). Taken from McGonigle and Lummis, 2010, with copyright 
permission from ACS Biochemistry. 
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Discussion 
 
 
4.3 Discussion 
 
In the present study I have examined the characteristics of agonist binding in 
RDL receptors, which are GABA-gated chloride selective Cys-loop receptors 
found in insect nervous systems. They are important to understand as 
insecticidal targets, and knowledge of their structure and function could clarify 
how these receptors function in other species.  I have created a homology 
model of the RDL binding site, and demonstrated that GABA and a range of 
GABA analogues can dock into this site with a range of potential interactions 
with binding site residues.  I have also examined the characteristics of the 
agonists and, using functional and modelling data, described the critical 
features required to activate these receptors.  
 
The GABA-gated chloride channels produced when RDL subunits are 
expressed in Xenopus oocytes have distinct pharmacological characteristics to 
the vertebrate GABAA receptors: they are activated by GABA with an EC50 of 
~20 µM; they exhibit minimal desensitization; they can be inhibited by PTX 
but not by bicuculline and they can be activated by the GABAA receptor 
agonist muscimol and the GABAC receptor agonist TACA.  Muscimol, which 
is a full agonist of GABAA receptors and a partial agonist of GABAC receptors, 
is a full agonist at RDL receptors, while THIP, which is a full agonist of 
GABAA receptors and an antagonist of GABAC receptors, is a partial agonist at 
RDL receptors. These characteristics are similar to GABA-gated receptors in 
cockroach neurons as previously reported (Sattelle et al., 1988; Schnee et al., 
1997). Other GABA-gated channels that have been heterologously expressed 
include those from Musca (MdRdl) and Laodelphax, where GABA-gated anion 
channels were identified with similar GABA EC50 values; these findings are 
similar to GABA-gated chloride channels in lobster, cockroach, and crab 
neurons and are in contrast to those of GABA-gated cation channels that have 
been identified in Caenorhabditis elegans, small crab, and Drosophila (Beg 
  87 
and Jorgensen, 2003; Duan and Cooke, 2000; Eguchi et al., 2006; Gisselmann 
et al., 2004; Swensen et al., 2000). 
Our examination of the GABA agonists suggests that GABA activates RDL 
receptors in the extended conformation, with agonist optimum length of ~5Å. 
This is similar to the extended conformation of GABA at GABAC receptors but 
differs to the partially folded conformation of GABA at GABAA receptors 
(Verdonk et al., 2003). 5-AV, which is one CH2 longer than GABA, and β-
alanine, which is one CH2 shorter, can also activate the receptors, suggesting 
that they are both close enough in size to generate essential contacts within the 
binding site, although the potencies of both these compounds (EC50 ~1 mM)  
are considerably less than GABA.  Glycine, which is two CH2 groups smaller 
than GABA, is inactive, as is tyramine, which is considerably larger than 
GABA.  Similarly, a correlation between agonist affinity and agonist length has 
been previously shown in GABAA receptors where affinity is correlated with 
ligand length, with a decreased binding rate for shorter ligands, suggesting a 
length-based selectivity mechanism at these receptors (Jones et al., 1998). 
 
Replacement of the ligand carboxylate group with a hydroxyl, as in 4-AB, 
results in an inactive ligand, confirming the requirement for an anionic group at 
this point of the ligand. Taurine, which is an analogue of β-alanine with the 
carboxylate replaced by a sulphonate, can also act as an agonist, although its 
low potency indicates that sulphonate does not substitute very effectively for 
carboxylate. Replacement of the carboxylate with a phosphoric acid group, 
however, as in 3-APP, results in an inactive ligand, demonstrating that the type 
of acidic group is important. 3-APP also had no antagonistic properties at RDL 
receptors which is in contrast to GABAC receptor data, where replacement of 
the carboxylic acid group of GABA with a phosphonic acid, phosphinic acid or 
sulphonic group produces potent antagonists (Woodward et al., 1993).  
The ammonium group is also critical. GHB, the well known “date rape” drug, 
is an analogue of GABA with the ammonium group replaced by a hydroxyl. 
This compound had no activity at RDL receptors.   
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The data therefore support the requirement for a charged dipole for receptor 
activation, suggesting electrostatic interactions with binding site residues are 
important. Computational ligand calculations reveal a partial negative charge at 
the carboxylate moiety and a partial positive charge at the ammonium moiety 
for all active agonists. Thus, since the most potent ligands have a dipole 
distance close to 5 Å, and both ends of the ligand are thought to interact with 
the receptor, we can assume that the agonist binding site lies at the cleft 
between the binding loops with a distance of ~5 Å from one another. This 
suggests that loops B, C, and D comprise the part of the binding site with 
which agonists interact in this receptor, as placement of ligands between the 
other loops would require a longer ligand.   This hypothesis is supported by the 
model which shows that loops B, C, and D form a clearly defined pocket in 
which the ligands bind (Fig. 4.3).  
 
Docking of ligands identified several residues with hydrogen bonding potential, 
in particular in loops B and C, which have been shown to have important 
contact points for ligands in 5-HT3, nACh, glycine and GABAC receptors 
(Beene et al., 2002; Lummis et al., 2005b; Pless et al., 2008; Thompson et al., 
2008). Most of the agonists (GABA, β-alanine, TACA and taurine) could form 
a hydrogen bond with S205 (loop B), and TACA and taurine could also form 
H-bonds with E204 (also loop B). Muscimol and isoguvacine could form H-
bonds with loop C residues L249 and Y254 respectively.  
 
The ammonium group of all the functional agonists docked between loop B and 
loop C aromatics (F206 and Y254 respectively) suggesting a cation-π 
interaction.  All Cys-loop receptors studied to date have been shown to have a 
cation-π interaction with an aromatic residue in the binding pocket and the 
ammonium of their natural ligand, although the location of the interacting 
residue varies from receptor to receptor.  Such interactions have mostly been 
with loop B aromatics (in nACh, 5-HT3, Gly and GABAC receptors), but 
interactions with loop C (MOD-1) and loop A (GABAA) aromatics have also 
been reported (Mu et al., 2003; Padgett et al., 2007).  
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Conclusion 
 
4.4 Conclusions 
 
In conclusion, I have identified the charge and dipole requirements for agonist 
recognition in RDL receptors and have identified residues within loop B, loop 
C and loop D which could interact with agonists.  I have also shown that loop 
B and/or loop C aromatic residues could contribute to the binding and/or 
function of the receptor via a cation-pi interaction. The data therefore provide a 
model of the agonist binding site, which can be used for further structure 
activity studies and rational drug design. 
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Chapter 5 
 
Investigating the GABA binding site of RDL 
receptors 
______________________________________________ 
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Introduction 
 
 
5.1 Introduction 
 
The aim of this chapter was to characterise putative binding site residues in 
order to assess the accuracy of my binding site model. I use mutagenesis to 
assess the effect of altering the side chains of residues identified as potentially 
important in agonist binding. The effects of these substitutions are assessed by 
TEVC, monitoring changes in the concentration-response relationship with 
GABA.  
‘Binding’ residues in the homologous GABAA receptor have been identified 
within the extracellular loops using mutagenesis, single-channel analysis and 
homology modelling: several aromatic residues form an ‘aromatic box,’ a 
hydrophobic surface favourable for ligand stabilisation. Hydroxylated residues 
and charged residues are also involved in GABA binding through direct salt-
bridge or hydrogen bonding interactions (Amin and Weiss, 1993; Boileau et 
al., 2002; Newell and Czajkowski, 2003; Wagner et al., 2004; Westh-Hansen et 
al., 1997; Westh-Hansen et al., 1999). Furthermore, aromatic residues from 
loops A, B, C and D have been found to form an aromatic box stabilising 
ligand binding in other Cys-loop receptors and several studies have in fact 
identified these regions as the binding site (Bartos et al., 2009b; Lummis, 2009; 
Lummis et al., 2005b; Melis et al., 2008; Padgett et al., 2007; Pless et al., 
2008; Thompson et al., 2008; Wagner et al., 2004; Xiu et al., 2009). 
Homology modelling and docking experiments on RDL receptors in Chapter 4 
led to the identification of several candidate binding residues (See Fig. 5.1). 
These residues are in similar regions to binding residues in the homologous 
GABAA receptor. I determine the importance of Loop B residues F206, Y208, 
E204 and S205, assessing the role of aromaticity, hydroxylation and charge. 
Loop C residues Y254 and R256 as well as Loop D residues Y109 and adjacent 
residue R111 are investigated, as well as Loop A aromatic residues F146 and 
F147. The aromatic residues investigated here are conserved across many of 
the Cys-loop receptors (See Fig. 1.2) and may well be important in ligand 
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binding. Indeed, in all of the mammalian Cys-loop receptors studied to date, a 
cation-π interaction with the native ligand has been identified, highlighting the 
importance of aromatic residues in ligand-binding. Additionally, charged 
residues may be involved in salt-bridge or electrostatic interactions with the 
charged ends of GABA and the charged residues investigated here may be 
involved in such interactions. Such interactions seem likely, given the 
requirement for a charged dipole as shown in the previous chapter. Thus, here I 
aim to identify the partner binding residues for GABA in the RDL binding site. 
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Figure 5.1 Binding site model. Above: Ribbon model of the RDL extracellular domain with 
GABA docked into its binding site. Loops A (Blue), B (Yellow), C (Green), D (Red), E 
(Black) and F (Purple) are highlighted. Below: Close up view of the putative agonist binding 
site with GABA docked and important residues labelled. Atomic colour scheme: Red 
(Oxygen); Blue (Nitrogen); Grey (Carbon); White (Hydrogen). Loops A-E are shown in wire 
format and coloured as above. 
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Results 
 
 
5.2 Results 
 
5.2.1 Molecular biology 
 
Mutagenesis PCR reactions yielded a DNA product of the expected size (6 kb), 
confirming the successful amplification of the pGEMHE vector (Fig. 5.2). 
Digestion of mini-prep DNA from E.coli colonies transfected with PCR 
product allowed the identification of mutant DNA samples (Fig. 5.3). 
 
 
Figure 5.2 Gel screen showing PCR product 
 
 
 Figure 5.3 Analysis of wild-type (WT) and mutant (Mut) DNA as revealed by the 
mutagenic removal of a reporter restriction site (HindIII).  Samples show the removal of a 
HindIII site in the mutant DNA (mut), confirming the mutation has been incorporated. 
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5.2.2 Loop B mutants 
 
Loop B is an important region of the Cys-loop receptor binding site and 
residues in this loop have been shown to be critical for ligand binding and/or 
receptor activation; specifically, aromatic residues in loop B have been shown 
to be critical, forming a cation-π interaction with the native ligand in the 5-HT3, 
Glycine, GABAC and nACh receptors (Beene et al., 2002; Thompson et al., 
2008; Lummis et al., 2005b; Zhong et al., 1998; Pless et al., 2008). 
Furthermore, charged residues in loop B have also been shown to be critical for 
receptor function in the 5-HT3 receptor (Thompson et al., 2008). For these 
reasons, charged and aromatic residues in RDL loop B were investigated. 
 
F206 
Mutation of F206 to alanine (F206A) resulted in an increase in EC50 for GABA 
(53 µM), from 20 µM in wild-type receptors, and a reduced Hill coefficient of 
0.9 (Fig. 5.4; Table 5.1) (Hill coefficient is 1.8 in wild type receptors). The 
reduction in the Hill coefficient to 0.9 would suggest that cooperativity within 
the receptor has been reduced.  
 
Mutation of F206 to tyrosine (F206Y) resulted in an EC50 of 0.5 µM (a 38-fold 
decrease from wild type). There was no significant change in Hill coefficient 
for F206Y, which would suggest that cooperativity has not been altered. β-
alanine was tested on this mutant to assess whether the gain of function was 
GABA specific or observable for other agonists. β-alanine had an EC50 of 17 
µM, which is a 47-fold decrease in EC50, comparable to the change for GABA 
(Table 5.1). Since β-alanine showed a near parallel shift in EC50 with GABA, it 
is likely that the biophysical affects of the F206Y mutation affect these two 
ligands similarly. Such a large gain in agonist sensitivity would suggest that 
this residue may contribute to ligand binding and/or receptor gating. 
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Figure 5.4 Concentration-response curves for F206 mutations. Above: GABA and β-
alanine concentration-response curves for F206A, F206Y and wild type (WT) receptors. Each 
data point is the mean ± SEM for at least four oocytes. Below: Sample electrophysiological 
traces showing maximal and approximately EC50 currents from wild type and mutant 
receptors.  
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Y208 
Loop B residue Y208 did not feature prominently in the binding site model, 
however its proximity to F206 prompted close attention to this region. Y208 
was predicted to point away from the GABA binding site, pointing inwards 
towards the core of the extracellular domain. The effect of mutating this 
residue and also coupling the Y208F mutation to the F206Y mutation was 
assessed to identify potential interactions between these residues. Mutation of 
Y208 to phenylalanine (Y208F) yielded functional receptors with a GABA 
EC50 of 71 µM (a 3.7-fold increase from wild type) with no significant change 
in the Hill coefficient. This mutation increased the EC50 for β-alanine to 2.8 
mM (a 3.5-fold increase from wild type). Similarly, mutation of Y208 to serine 
(Y208S) resulted in a GABA EC50 of 47 µM (a 2.5-fold increase from wild 
type), with no change in Hill coefficient (Fig. 5.5; Table 5.1). 
The double mutant F206Y.Y208F had a GABA EC50 of 3.6 µM, with a Hill 
coefficient of 1.1. Double mutant cycle analysis of these two residues shows 
that they are coupled with interaction energy of 1.7 kJ/mol (Fig. 5.6). 
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Figure 5.5 Concentration-response curves 
and sample electrophysiological traces for 
Y208 mutations. Above: GABA 
concentration-response curves and sample 
traces for Y208F, Y208S and double mutant 
206Y.208F. Below: β-alanine concentration-
response curve and sample traces for Y208F. 
Each data point is the mean ± SEM for at least 
four oocytes. 
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Figure 5.6 Mutant cycle analysis for mutants Y208F, F206Y and double mutant 
F206Y.Y208F. A coupling energy of 1.7 kJ/mol suggests that the effects of these mutations 
on receptor function are coupled. This suggests that these residues are situated close together 
in an orientation which may contribute to the GABA binding site. Values of Ω > 2.5 have 
been shown to identify direct interactions between molecular groups (Schreiber et al., 1995). 
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E204 
Loop B glutamate (E204) was mutated to alanine (E204A) and aspartate 
(E204D). Xenopus oocytes injected with 50 ng of cRNA for these mutants 
failed to give responses to GABA, suggesting that GABA binding or gating has 
been disrupted.  
 
S205T 
Loop B serine (S205) was mutated to threonine (S205T) and alanine (S205A), 
to test whether this residue is critical to receptor function. Oocytes injected 
with 50 ng of cRNA for these mutants failed to give responses to GABA.  
 
 
5.2.3 Loop C mutants 
 
Loop C is an important part of the ligand binding site in Cys-loop receptors; 
recent studies have suggested that loop C moves in a ‘capping motion’ during 
agonist binding (Ulens et al., 2009; Hansen et al., 2005) and previous studies 
have demonstrated a role for aromatic and charged residues in agonist binding 
in the related 5-HT3, GABAA and GABAC receptors (Padgett et al., 2007; 
Beene et al., 2007; Harrison and Lummis, 2006). For these reasons, aromatic 
and charged residues in RDL loop C were investigated to determine their role 
in agonist binding. 
 
Y254 
Loop C tyrosine (Y254) was mutated to alanine (Y254A) and phenylalanine 
(Y254F). Oocytes injected with Y254A cRNA failed to give responses to 
GABA. Y245F mutant receptors had an increased GABA EC50 of 124 µM 
(6.5-fold greater than wild-type), with no significant change in Hill coefficient. 
Testing of β-alanine on this mutant revealed an EC50 of 1800 µM, a 2.2-fold 
increase compared with wild-type receptors (Fig. 5.7; Table 5.1). 
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Figure 5.7 Concentration-response curves for mutant Y254F. Above: GABA and β-
alanine concentration-response curves for Y254F mutant receptors. Each data point is the 
mean ± SEM for at least four oocytes. Below: Sample electrophysiological traces.  
 
R256 
Functional responses from mutant receptors R256K and R256A could not be 
detected following 50 ng RNA injection, suggesting that binding and/or gating 
has been disrupted. 
 
5.2.4 Loop D mutants 
 
Loop D forms part of the agonist binding site in Cys-loop receptors (Akabas, 
2004); in the GABAA receptor an aromatic residue (α1Phe65) has been shown 
to form part of the “aromatic box,” allowing ligand binding, and in the GABAC 
receptor, a charged residue (R104) was shown to be critical to agonist binding 
(Harrison and Lummis, 2006). The homologous residues to these in RDL 
(Y109 and R111) were mutated to determine their role in ligand binding.  
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Y109 
Mutation of Loop D tyrosine residue Y109 to alanine (Y109A) failed to give 
responses following injection of 50 ng cRNA. Similarly, mutation of the same 
residue to a serine (Y109S) also failed to give responses. However, mutation to 
phenylalanine (Y109F) resulted in functional receptors with a GABA EC50 of 
398 µM (21-fold increase from wild type), but with no change in Hill 
coefficient (Fig. 5.8; Table 5.1).  
 
 
Figure 5.8 Concentration-response curve and sample traces for mutant Y109F. Each data 
point is the mean ± SEM for at least four oocytes. 
 
R111 
Mutation of Loop D arginine residue R111 to alanine (R111A) or lysine 
(R111K) failed to give responses following injection of 50 ng cRNA. 
Since R111 is positioned next to Y109 in a β-sheet region it was suspected that 
these residues may be interacting with each other via a cation-π interaction. 
This is a likely interaction, as there is on average 1 cation-π interaction for 
every 77 amino acids in the protein data bank. Also, it is known that 
Tyr/Trp···Lys/Arg motifs contribute significantly to stabilising protein 
secondary structure (Dougherty, 2007). As part of an Arg-X-Tyr motif, this 
residue is likely to be involved in an interaction with Y109. However, 
responses could not be detected from R111Y.Y109R injected oocytes, 
suggesting that functional receptors could not be formed.  
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5.2.5 Loop A mutants 
  
A loop A aromatic residue (β2Tyr97) has been shown to be important in the 
human RDL orthologue, the GABAA receptor, where a cation-π interaction 
between the ammonium of GABA and β2Tyr97 has been detected (Padgett et 
al., 2007). Although in my homology model the candidate loop A aromatic 
residue (F147) was predicted to be quite distant from the ammonium of GABA 
(See Fig. 5.1), it was thought important to investigate this residue in order to 
validate my model. 
 
F146 
F146 was assessed to determine if it is involved in agonist binding and/or 
receptor activation. Mutation of this phenylalanine residue to alanine (F146A) 
resulted in a GABA EC50 of 90 µM, with no change in Hill coefficient (Fig. 
5.9; Table 5.1). 
 
 
Figure 5.9 Concentration-response curve and sample traces for mutant F146A. Each data 
point is the mean ± SEM for at least four oocytes. 
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F147 
F147 is positioned adjacent to F146 in the β-sheet region of loop A. The side 
chain of F147 was predicted by my homology model to face towards the 
central core of the protein, away from the binding site cleft. This residue was 
mutated to alanine but no responses were detected from this mutant.  
 
Table 5.1 Parameters derived from concentration-response curves. 
Mutant pEC50(µM) ± SEM EC50(µM) nH ± SEM n 
GABA evoked responses 
WT       4.705 ± 0.039 19.7 1.8 ± 0.2 19 
F206A 4.278 ± 0.063* 53 0.9 ± 0.1* 5 
F206Y 6.342 ± 0.026* 0.5 1.7 ± 0.2 8 
Y208F 4.149 ± 0.032* 71    1.7 ± 0.3 6 
Y208S 3.839 ± 0.029* 47 2.2 ± 0.3 5 
F206Y. Y208F 5.447 ± 0.078* 3.6 1.1 ± 0.2 6 
E204D N/R - - - 
E204A N/R - - - 
S205T N/R - - - 
S205A N/R - - - 
Y254F 3.910 ± 0.041* 124 2.3 ± 0.5 5 
Y254A N/R - - - 
R256K N/R - - - 
R256A N/R - - - 
Y109F 3.400 ± 0.060* 398 1. 7 ± 0.4 4 
Y109S N/R - - - 
Y109A N/R - - - 
R111K N/R - - - 
R111A N/R - - - 
Y109R. R111Y N/R - - - 
F146A 
 
4.044 ± 0.061* 90 2.0 ± 0.6 4 
F147A N/R - - - 
β-alanine evoked responses 
WT       3.096 ± 0.030 801 2.0 ± 0.3 10 
F206Y 4.770 ± 0.058* 17 2.0 ± 0.4 4 
Y208F 2.567 ± 0.035* 2835 2.6 ± 0.5 4 
Y254F 2.745 ± 0.050* 1800 2.1 ± 0.4 6 
N/R indicates no response, nH is the Hill coefficient, n indicates number of replicates. * 
denotes significance from WT (p<0.05, t-test). 
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 5.2.6 Probing binding site mutations using the gain of function mutant 
L314Q 
 
The RDL mutation L314Q (M2 14' residue) was reported by Hosie et al. to 
induce spontaneous channel opening with a 200-fold decrease in GABA EC50 
(Biochemical Society Summer Meeting, St Andrews, July 2009). The 14' 
residue lies close to the 16' residue in the adjacent subunit and he proposed that 
the interaction of these residues could influence closed state stability. Cysteine 
substitution of 14' and 16' markedly reduced the amplitude of GABA 
responses. Reduction of disulphide bonds with DTT restored large amplitude 
GABA responses suggesting these residues are interacting directly. 
Spontaneously open channels can be detected by applying picrotoxin (PTX) in 
the absence of agonist. A rise in the baseline current is indicative of open 
channels being blocked by PTX. 
 I felt that the L314Q mutation would make a useful reporter for changes in the 
intrinsic open channel probability of the receptor. By coupling a gain/loss of 
function mutation to the L314Q mutation, changes in the proportion of open 
channels, as measured by PTX block, can be used to indicate whether the 
mutation of interest can affect gating in an agonist independent manner.  
 
L314Q 
Cells expressing L314Q mutant receptors displayed a large leak current. 
GABA evoked responses recovered very slowly when compared to wild type. 
PTX induced a rise in the current indicative of channel block and channels 
recovered slowly requiring several agonist applications (Fig. 5.10). 
 
F206Y.L314Q 
F206Y.L314Q receptors displayed a large leak current and GABA evoked very 
small or no currents (Fig. 5.10). Mean maximal GABA currents were compared 
to the amplitude of PTX induced block to give an estimation of the proportion 
of channels that are spontaneously open (Fig. 5.10). The open channel 
population for F206Y.L314Q was compared to that for L314Q (Fig. 5.11).  
This ratio was found to be 2.9, indicating that the introduction of the F206Y 
mutation increased the proportion of open channels by 2.9-fold. 
  106 
 
 
 
 
Figure 5.10 Electrophysiological traces for L314Q and F206Y.L314Q mutations. GABA 
and PTX were applied at EC100 and IC100 concentrations (100 µM). 
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Figure 5.11 F206Y.L314Q open channel proportions. Above: Changes in open channel 
proportions (PO) with F206Y mutation. Above: Relative amplitudes of maximal GABA 
currents (B) and PTX induced block (A) for L314Q and F206Y.L314Q mutants were 
calculated and open proportions were plotted as [A/(A+B)] . Data points are mean ± SEM, 
n≥10. Data are significantly different (p<0.0001, t-test). Below: Open channel proportions 
(PO) calculation and Gibbs free energy of gain/loss of function. Where A is I[PTX]Max, B 
is  I[GABAMax], R is the universal gas constant (8.314 J.K
-1.mol-1), T is the temperature in 
Kelvin (°K = °C + 273.15), where mut2 is the double mutant and mut1 is the L314Q mutant. 
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If the increase in PTX-induced block is a direct reflection of an increase in the 
proportion of receptors in the open state then we can use the relative open 
proportions for the mutant and wild type receptors to calculate the free energy 
of gating associated with the mutation of interest. This value is an indirect 
measure of the effects on intrinsic receptor gating, as introduced by the F206Y 
mutation (Fig. 5.11). This energy should therefore represent an interaction 
between mutant residue F206Y and another extracellular domain residue, since 
no agonist is present in this experiment. 
 
The change in Gibbs free energy for activation of mutant F206Y receptors is 
8.9 kJ/mol (RTln[38]), as calculated using the 38-fold increase in GABA EC50 
(EC50Mut/EC50WT). This value is close to the value for a single hydrogen 
bond. This finding led to the hypothesis that the mutant residue F206Y is 
interacting with another residue in the ECD in a fashion that favours receptor 
activation. Since the phenolic oxygen is capable of such an interaction, a 
hydrogen bond acceptor residue is a likely candidate for interaction. This 
prompted a further analysis of the RDL ECD homology model, identifying 
Loop E residue S176, which is predicted to lie close, within 3.1 Å, of F206 
(Fig. 5.12). 
 
 
 
Figure 5.12 Distance between loop B F206 and Loop E S176. F206 is predicted to lie 3.1 Å 
from S176. With the addition of the phenolic hydroxyl, as in the mutation F206Y, an 
interaction, such as a hydrogen bond, may occur between S176 and Y206. 
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The F206Y mutation increased the open proportion of receptors by 2.9-fold. 
This increase in intrinsic gating conferred by the 206Y mutation does not fully 
account for the 38-fold gain of function, as revealed by EC50 value for GABA. 
This suggests that though the addition of a hydroxyl group can confer a gain of 
function, the intrinsic gating component does not fully account for the much 
larger decrease in agonist (GABA and β-alanine) EC50 values. This finding 
therefore supports the hypothesis that F206 forms part of the agonist binding 
site, possibly via a cation-π interaction with the ammonium of GABA. 
 
According to the Del Castillo-Katz receptor activation scheme, receptor 
activation involves distinct steps of agonist binding and receptor gating (K and 
Ø) (Fig. 5.13) (Del Castillo and Katz., 1957). This basic theory has been since 
expanded upon to include many more hypothetical states but its basic premise 
remains widely accepted (Burzomato et al., 2004; Corradi et al., 2009; Miller 
and Smart, 2010). The open probability of the channel is therefore the product 
of both of these hypothetical biophysical properties, binding and gating. If the 
gain of function from the F206Y mutation is the product of both an increase in 
binding energy as well as an decrease in gating energy, we can use the Del 
Castillo-Katz equation to calculate the value of these separate components. The 
change in binding energy for GABA with the F206Y mutation was thus 
calculated to be 3.4 kJ/mol (Fig. 5.13). 
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Del Castillo-Katz 
 
 
Figure 5.13 Change in binding energy for the F206Y mutation. Above: Del Castillo-Katz  
equation. Ø is the gating coefficient. K represents the equilibrium constant for ligand binding 
steps.  While in this scheme only two agonist binding events are displayed, a theoretical 
maximum of five agonists may bind a receptor. This simple scheme shows how binding of an 
agonist precedes channel opening. Below: Calculation of binding energy using the Del 
Castillo-Katz rationale and the Gibbs free energy equation where, R is the universal gas 
constant (8.314 J.K-1.mol-1), T is the temperature in Kelvin (°K = °C + 273.15), Ø represents 
the gating energy and K represents the change in binding energy for GABA. 
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Y254F.L314Q 
Y254F.L314Q mutant receptors displayed a large leak current and significant 
GABA evoked currents could not be detected (Fig. 5.14). Y254F mutant 
receptors showed an increase in the intrinsic gating pathway with a theoretical 
open channel proportion of 100%.  
 
 
 
 
Figure 5.14 254F.314Q open channel proportions. Above: Relative amplitudes of maximal 
GABA currents and PTX induced block for 314Q and 254F.314Q mutants. Data points are 
mean ± SEM, n≥4. Data are significantly different (p<0.0001, t-test). Below: Relative open 
channel proportions (PO) of receptors. 
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The change in Gibbs free energy for the Y254F mutation is -4.6 kJ/mol, as 
calculated using the 6.5-fold increase in EC50 for GABA (Fig. 5.15). Using the 
Del Castillo-Katz rationale to calculate the change in GABA binding energy 
with this mutation, taking Ø, the gating coefficient to be equal to the open 
probability, revealed a change in binding energy of -1.6 kJ/mol (Fig. 5.15). 
 
 
 
Figure 5.15 Loss in binding energy for 254F mutation. Calculation of binding energy using 
the Del Castilo-Katz rationale and the Gibbs free energy equation where, R is the universal 
gas constant (8.314 J.K-1.mol-1), T is the temperature in Kelvin (°K = °C + 273.15). Ø 
represents the gating energy and K represents the binding energy. 
 
 
Y109F.L314Q 
No GABA currents could be detected from oocytes injected with 
Y109F.L314Q mutant cRNA. Additionally no PTX induced change in current 
could be detected and oocytes displayed a low level of leak current, indicating 
that receptors were not being expressed or that channels could not be opened. 
This suggests that these two mutations, although individually both resulting 
functional receptors, when combined have deleterious effects on receptor 
expression. This finding would suggest that these mutations disrupt receptor 
folding or trafficking to the cell surface. 
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Discussion 
 
 
5.3 Discussion 
 
In this chapter I have characterised the agonist binding site of RDL receptors. I 
have used mutagenesis to determine which residues are critical to ligand 
binding. I have focused on residues in loops A, B, C and D, regions which are 
known to contain binding residues in several other Cys-loop receptors. 
Loop B residue F206 was found to be sensitive to mutation, with an alanine 
substitution disrupting cooperativity, as evinced by a reduced Hill coefficient, 
and with a tyrosine mutation greatly increasing agonist sensitivity. This residue 
is equivalent in location to conserved aromatic residues in 5-HT3, GABAA, 
GABAC and nACh receptors, where the equivalent residues have been shown 
to be key binding residues and specifically forming a cation-π interaction with 
the native ligand in 5-HT3 and GABAC receptors (Beene et al., 2002; Lummis 
et al., 2005b; Padgett et al., 2007; Thompson et al., 2008; Zhong et al., 1998). 
Further analysis of F206, by incorporating the L314Q reporter mutation, which 
causes spontaneous channel opening, revealed that this residue plays a role in 
both ligand binding as well as channel gating in RDL receptors. The change in 
binding energy for GABA associated with the F206Y mutation was found to be 
3.4 kJ/mol. This value is greater than the difference in cation-π forming ability 
of tyrosine and phenylalanine (Dougherty, 1996; Mecozzi et al., 1996), 
suggesting that a direct interaction between the phenolic oxygen of mutant 
residue F206Y and GABA may occur. This finding fits well with work on the 
homologous residue in other Cys-loop receptors and suggests that RDL 
receptors bind GABA in a similar fashion to the binding of ligands in 
vertebrate Cys-loop receptors. 
Loop B residue Y208 was found not to be a binding residue, however it is 
energetically coupled to F206 and plays a role in receptor gating. These results 
suggest that this region of loop B is involved in receptor activation and is 
sensitive to mutation. This finding fits well with a recent structure-function 
study of loop B in the related 5-HT3R, which showed that many residues in 
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loop B are essential for receptor function via both structural stabilisation of 
loop B and direct ligand binding (Thompson et al., 2008). The position of 
Y208 as predicted by my homology model, facing into the hydrophobic core of 
the extracellular domain, is consistent with such a structural stabilisation. 
The Loop B residue E204 was found to be critical to receptor function. 
Currents could not be recorded from mutants E204D or E204A. Since neither 
of these mutants responded, it seems likely that this residue is important for 
receptor activation or receptor folding. E204 is situated close to F206, which is 
important in receptor activation. It thus seems probable that this region of Loop 
B is sensitive to mutations and those residues likely to be involved in structural 
roles, such as charged residues, cannot be mutated without deleterious effects. 
Mutation of the homologous residue in the 5-HT3R (a threonine) to either an 
alanine or a serine resulted in non-functional receptors, although receptors 
expressed and formed a binding site and radioligand binding studies (using an 
antagonist) showed a six-fold increase in binding affinity for the alanine 
mutation and no change for the serine mutant when compared to wild type 
receptors (Thompson et al., 2008). This suggests a critical role for this residue 
in receptor activation. My results are therefore similar to those of Thompson et 
al. (2008), since no functional receptors could be detected. Docking 
simulations from the previous chapter show the ammonium of GABA to be 
positioned 6.7 Å from E204 (Fig. 5.16). Although the distance here exceeds the 
predicted length of a salt-bridge of ~4 Å (Kumar and Nussinov, 2002) this 
finding should leave open the possibility for such an interaction.  
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Figure 5.16 Electrostatic polarity of GABA within the binding site. GABA docked with 
the carboxylate group 3.7 Å from Loop D residue R111 and with the ligand ammonium 6.7 Å 
from Loop B residue E204. 
 
Loop B residue S205 is one of very few residues conserved across the Cys-loop 
receptor family (See Figure 1.2). It is thus unsurprising that mutations made to 
this residue are not tolerated. This residue is located next to F206, which has 
proven to be a key determinant of agonist sensitivity. It is probable that 
mutations at position 205 disrupt the structure of Loop B, since even the 
conservative mutant S205T failed to respond. Mutation of the homologous 
residue in the 5-HT3 receptor (also a serine) to both alanine and threonine 
resulted in a two and four-fold decrease in binding affinity respectively, with 
only the threonine mutant showing functionality, with a three-fold increase in 
EC50. Further investigations into this residue should utilise unnatural amino 
acids which can monitor very subtle changes in side chain chemistry without 
the deleterious effects observed here. 
 
Loop C residue Y254 was found to be important in ligand binding. Mutation of 
Y254 to alanine (Y254A) resulted in non-functional receptors. This is 
unsurprising since Y254 is a conserved residue across many Cys-loop 
receptors, suggesting an important functional or structural role. The Y254F 
mutation however, resulted in an increase in GABA EC50, suggesting that 
subtle changes at this location can affect receptor function. Additionally, this 
result supports the hypothesis that the tyrosine phenolic hydroxyl group is 
involved in ligand binding and/or receptor activation. Analysis with the 
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reporter mutation L314Q revealed that the energy of binding between GABA 
and Y254 is less than a single hydrogen bond, suggesting that a cation-π 
interaction may occur here. Furthermore, docking simulations in the previous 
chapter, placed the ammonium of GABA between F206 and Y254 (Fig. 5.17), 
suggesting that Y254 may well form a cation-π interaction with the ammonium 
of GABA. This would be similar to the interaction observed in the C.elegans 5-
HT-gated channel MOD-1 (Mu et al., 2003). Proximal Loop C residue R256 
was also found to be critical to receptor activation and/or formation. Since this 
residue was not prominent in docking simulations carried out in the previous 
chapter, I feel that this residue is more likely to be involved in receptor 
structure rather than ligand binding. However, in a study of the homologous 
residue in the GABAC receptor, R249 was substituted with alanine, glutamate, 
or aspartate with relatively small (4–30-fold) increases in GABA EC50 
(Harrison and Lummis, 2006). This would suggest that this residue may play 
different roles in different receptors, with it perhaps being more important in 
RDL. 
 
 
 
 
Figure 5.17 Aromatic box residues. Above: 
Wire diagram of the binding site with aromatic 
box residues Y109, F206 and Y254 in space 
filling representation, with GABA docked. 
Below: Close up view of GABA docked with 
the ammonium group sandwiched between the 
faces of aromatic residues F206 and Y254. 
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Mutation of Loop D residue Y109 to alanine resulted in non-functional 
receptors and the conservative phenylalanine mutation resulted in a large rise in 
GABA EC50. This residue is thus critical to GABA sensitivity. Indeed, the 
homologous residue in the GABAA receptor (α1Phe65) has been shown to be 
involved in ligand binding by increasing the “general hydrophobicity of the 
region,” showing a requirement for aromaticity at this position (Padgett et al., 
2007). However another study of the same residue in GABAA receptors 
showed that mutation to leucine increased the GABA EC50 from 6 to 1260 µM,
 
with the IC50 values of bicuculline and SR95531 (competitive antagonists) 
increasing by similar amounts (Sigel et al., 1992). This would suggest an 
important role in ligand binding. The position of this residue in the ECD 
homology model supports the hypothesis that this residue forms part of the 
aromatic box in this receptor, providing a hydrophobic surface for water 
exclusion and ligand stabilisation close to the predicted GABA binding 
location (Fig. 5.17). The adjacent residue R111 was found to be a key binding 
residue in RDL receptors with R111K and R111A mutants failing to respond. 
R111 is predicted to lie 3.7 Å from the carboxylate of GABA, based on 
docking simulations (Fig. 5.16). A salt bridge interaction is likely to occur if 
the simulation is accurate. Furthermore, it has been shown in the GABAC 
receptor that the homologous residue (R104) is critical to receptor activation: 
when R104 is substituted with alanine or glutamate an increase in GABA EC50 
>10,000-fold was observed. In the same study, molecular modelling indicated a 
role of this residue in binding GABA (Harrison and Lummis, 2006). 
  
Loop A aromatic F146 was found not to be a binding residue in RDL receptors. 
Referring to the model predicted that the ammonium of GABA is 9.7 Å from 
the aromatic side chain of F146 (Fig. 5.18). The model is consistent with the 
observed experimental evidence in this chapter and suggests that this residue is 
not close enough to interact directly with GABA. Conversely however, this 
residue is of central importance to GABA binding in the GABAA receptor, 
where the equivalent aromatic residue (β2Tyr97), is involved in a cation-π 
interaction with the ammonium of GABA (Padgett et al., 2007). This would 
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suggest that GABA binds in a different position in RDL than in GABAA 
receptors. Adjacent residue F147 is predicted to face into the hydrophobic core 
of the extracellular domain (Fig. 5.18). Alanine substitution (mutation F147A) 
resulted in nonfunctional receptors. It is possible that the alanine substitution 
alters the tertiary structure of the β-sheet backbone of Loop A resulting in 
misfolded protein. The hydrophobic nature of this residue may be important in 
maintaining receptor structure or correct receptor folding.  
 
 
 
Figure 5.18 Loop A aromatic residues F146 & F147. GABA is positioned in its predicted 
binding orientation with its distance from F146 labeled. 
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Conclusion 
 
5.4 Conclusions 
 
RDL receptors are sensitive to mutations in Loop B, Loop C and Loop D 
aromatic residues (F206, Y254 and Y109 respectively), suggesting that these 
residues form the aromatic box involved in stabilising ligand binding. 
Furthermore, Loop B aromatic residues F206 and Y208 are energetically 
coupled, suggesting an interaction during receptor activation. However, Loop 
A aromatic residues are unlikely to be involved in GABA binding. 
Loop B glutamate and serine residues E204 and S205 may play important 
structural roles as well as being directly involved in ligand binding. In 
particular, the negatively charged side chain of E204 is likely to be involved in 
a salt-bridge interaction with the positive ammonium of GABA. 
A Loop D arginine residue (R111) is also critical to RDL receptor function and 
modelling and docking experiments predict a direct role for this residue in 
GABA binding.  
The mutation F206Y causes a large gain of function and this residue is 
predicted to form a cation-π interaction with the ammonium of GABA. 
Additionally, Loop C aromatic Y254 is sensitive to mutations and is predicted 
to interact with GABA, also via a cation-π interaction. Molecular modelling 
supports this hypothesis and this should be further tested using unnatural amino 
acid mutagenesis. 
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Chapter 6 
 
Characterisation of Ginkgo biloba extracts on RDL 
receptors 
______________________________________________ 
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Introduction 
 
6.1 Introduction 
  
The Ginkgo biloba tree has been used in Chinese medicine for over 2,500 years 
(Drieu et al., 2000) and is amongst the most used herbal medicines today. 
Ginkgo biloba extracts contain flavonoids (22-24%) and terpene trilactones (6-
8%) (DeFeudis and Drieu, 2000). Ginkgo biloba extracts are also potent 
insecticides, e.g. bilobalide has an LD50 of 0.26 ng/insect when tested on 
planthoppers, while ginkgolide A and ginkgolide B had values of 64 and 16 
ng/insect respectively (Ahn, 1997). These terpene trilactone compounds have 
been shown to be non-competitive antagonists of vertebrate glycine and 
GABAA receptors with IC50 values in the low micromolar range (Ivic et al., 
2003; Huang et al., 2004; Kondratskaya et al., 2004). Ginkgolides and 
bilobalide are therefore pharmacologically similar to picrotoxin (PTX) a non-
competitive antagonist of GABAA and glycine receptors (Ivic et al., 2003; Li 
and Slaughter, 2007). PTX has been well characterised as binding close to the 
2' channel-lining residue (Chen et al., 2006; Das and Dillon, 2005; Olsen, 
2006). Similarly, molecular modelling of the glycine receptor pore has yielded 
insight into the binding parameters of ginkgolide B, implicating a role for the 6' 
and 2' channel-lining residues (Hawthorne et al., 2006; Heads et al., 2008).  
  
The aim of this study was to assess the potency of ginkgolide A, ginkgolide B, 
bilobalide and picrotoxin (Fig. 6.1) on RDL receptor function and to determine 
the role of the 2' and 6' channel-lining residues. 
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Figure 6.1 Structures of picrotoxin (picrotoxinin) and ginkgolides. Ginkgolide A and 
ginkgolide B differ only by a single atom, the R1 group being a hydrogen atom and hydroxyl 
group respectively. Ginkgolides, bilobalide and picrotoxinin are all caged compounds. 
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Results 
 
 
6.2 Results 
 
6.2.1 Ginkgolides are antagonists of RDL receptors 
 
Co-application of ginkgolides and bilobalide with GABA resulted in 
diminished currents (Fig. 6.2), while pre-application (30 µM for 30 s) had no 
effect on subsequent GABA responses. Concentration-inhibition curves were 
prepared (Fig. 6.2) and IC50 values were 0.95 µM, 0.69 µM, 0.25 µM and 1.1 
µM for GA, GB, BB and PTX respectively (Table 6.2).  
Following ginkgolide inhibition (10 µM antagonist), receptors recovered 
slowly, with the effects of inhibition not fully reversed after twenty minutes of 
washout and four GABA applications (EC50) (Fig. 6.3).   
 
 
 
 
 
Fig. 6.2 Ginkgolides are antagonists of 
RDL receptors. Concentration-inhibition 
curves and sample electrophysiological 
traces showing the effects of ginkgolide A 
(GA), ginkgolide B (GB), bilobalide (BB) 
and picrotoxin (PTX) on GABA (EC50) 
evoked currents.  GABA evoked responses 
are diminished in the presence of all 
compounds. 
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Figure 6.3 RDL receptor recovery 
following ginkgolide inhibition. Above: 
Recovery time of wild-type RDL 
receptors following GA, GB, BB and 
PTX inhibition. PTX, BB, GB and GA 
inhibition (10 µM antagonist) was not fully 
reversed following four applications of 
GABA [EC50] and twenty minutes of saline 
washout. Each data point is mean ± SEM 
from at least three oocytes. Below: 
Electrophysiological traces showing 
recovery from inhibition. 
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6.2.2 Mutant receptors are resistant to antagonists 
 
Mutant receptors A2'S, T6'V and double mutant A2'S T6'V formed functional 
receptors with EC50 values of 23 µM, 75 µM and 21 µM respectively (Fig. 6.4) 
(Table 6.1). Both T6'V and A2'S mutant receptors showed decreased sensitivity 
to all compounds: IC50 values for T6'V were > 100 µM, 260 µM, > 1 mM and 
1.1 mM  for GA, GB, BB and PTX respectively; IC50 values for A2'S were 2.8 
µM, 10.1 µM, 160 µM and 260 µM for GA, GB, BB and PTX respectively 
(Table 6.2; Fig. 6.5). Double mutant A2'S T6'V was resistant to all compounds, 
with no effects observable with 100 µM antagonist. A2'S and T6'V mutant 
receptors also displayed accelerated recovery from antagonists when compared 
to wild type. Following antagonist withdrawal, A2'S and T6'V mutant receptors 
recovered fully with a subsequent GABA application.  
 
 
Figure 6.4 Concentration-response curves for mutants used in this study. Each data point 
is the mean ± SEM of at least three different oocytes 
 
 
Table 6.1 Parameters derived from concentration-response curves. 
Mutant EC50 ± SEM EC50  (µM) nH  ± SEM n 
WT 4.71 ± 0.04 19.7 1.8 ± 0.2 19 
A2'S 4.64 ± 0.06 22.7 1.9 ± 0.4 4 
T6'V 4.13 ± 0.06* 74.6 1.4 ± 0.3 9 
A2'S.T6'V 4.69 ± 0.06 20.6 2.1 ± 0.5 5 
 
nH is the Hill coefficient, n indicates number of replicates. * denotes significance from WT 
(p<0.05, t-test). 
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Figure 6.5 Ginkgolide inhibition of mutant RDL receptors. Above: Concentration-
inhibition curves prepared from mutant receptor responses. Antagonist was co-applied 
with GABA (EC50 concentration) and the inhibited response was normalised to response in 
the absence of antagonist. Each data point is the mean ± SEM of at least three different 
oocytes. Below: Electrophysiological traces showing the effects of 1 µM ginkgolide A 
(GA), ginkgolide B (GB), bilobalide (BB) and picrotoxin (PTX) on GABA (EC50) evoked 
currents.  A2'S and T6'V mutant receptors show resistance to these compounds.   
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Table 6.2 Parameters derived from concentration-inhibition curves. 
 
Antagonist pIC50 ± SEM IC50  (µM) nH ± SEM n 
Wild-type receptors 
PTX  5.976 ± 0.165 1.1 0.5 ± 0.1 3 
GA 6.024 ± 0.371 0.95 0.5 ± 0.2 3 
GB 6.118 ± 0.222 0.69 0.7 ± 0.3 4 
BB 6.610 ± 0.167 0.25 0.7 ± 0.2 4 
A2'S receptors 
PTX  3.593 ± 0.082* 260 1.1 ± 0.2 4 
GA   5.555 ± 0.052 2.80 1.3 ± 0.2 3 
GB 4.997 ± 0.111* 10.1 0.7 ± 0.2 4 
BB 3.800 ± 0.787* 160 0.5 ± 0.2 3 
T6'V receptors 
PTX  2.961 ± 0.185* 1090 0.9 ± 0.2 5 
GA ≤4 - - 3 
GB   3.588 ± 0.362* 260 1.0 ± 0.7 4 
BB ≤3 - - 4 
 
nH is the Hill coefficient, n = number of replicates. * denotes significance from wild-type 
(p<0.05, unpaired t-test). 
 
 
6.2.3 Mutant cycle analysis 
 
Mutant cycle analysis was carried out using IC50 values arrived at from 
concentration-inhibition curves. By assessing the effect of changing a single 
chemical group on the ligand both on wild-type and mutant receptors we can 
determine how coupled these two atomic groups are by calculating a coupling 
coefficient. Coupling coefficients suggest a positive interaction between the R1 
group of ginkgolide B and both the 2' and 6' residues. Interaction energies 
(∆∆G.int = -RTlnΩ) of 3.9 and 4.8 kJ.mol-1 for 2' and 6' residues respectively 
suggest a non-covalent interaction between ligand and receptor at this position 
(Fig. 6.6). This prediction at 6'T is in line with the expected energy of a single 
hydrogen bond (5-30 kJmol-1).   
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Figure 6.6 Mutant cycle analysis. For the 6' threonine residue the coupling energy (∆∆G.int 
= -RTlnΩ) was 4.8 kJmol-1. For the 2' alanine it was 3.9 kJmol-1.  
 
 
6.2.4 Molecular modelling and docking 
 
Ginkgolide A and ginkgolide B docked into the channel close to the 6'T residue 
(Fig. 6.7). Both compounds docked towards two of the M2 helical bundles. 
Hydrogen bonding with the carbonyl oxygen of the 6'T residue was detected 
for Ginkgolide A. Ginkgolide B docked into the same location in a similar 
orientation but the same H-bonding interaction with this residue was not 
detected. Picrotoxinin and bilobalide also docked within 5 Å of the 6' and 2' 
channel-lining residues of contiguous subunits; however no specific 
interactions were detected. In A2'S receptors, both ginkgolide A and ginkgolide 
B showed hydrogen bonding interactions with the 2'S residue whilst hydrogen 
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bonding at the 6'T residue was absent. Furthermore, both ginkgolide 
compounds docked in the same orientation at 2'S receptors, orientations distinct 
from that observed at wild type receptors, with both compounds inverted and 
lower in the channel. In T6'V receptors no hydrogen bonding interactions were 
observed for any compounds. 
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Figure 6.7 Homology models of the RDL transmembrane domain and docking 
simulations. A homology model of the full RDL pentamer based on Gloebacter violaceus 
(GLIC) (PDB: 3EAM). Two subunits were removed for the purpose of this figure, revealing 
the binding orientation within the pore. M2 transmembrane regions are α-helical (red, grey 
and green; denoting separate subunits). Above: GA, GB, BB and PTX docked into WT, A2'S 
and T6'V mutant receptors. Below: Close up view of GA and GB binding orientations in WT 
and A2'S mutant receptors, where hydrogen bonds were detected. 
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6.2.5 Insect bioassays 
 
Bioassays were carried out by Mirel Puinean and Martin Williamson at 
Rothamsted Research, Hertfordshire. After 48 h with an application of 1000 
ppm compound, two out of four compounds (BB and GA) produced 100% 
mortality. The difference between these compounds and GB and PTX could be 
observed after 1 h when most of the individuals dosed with BB and GA, 
although alive, had their hind legs paralyzed while the insects dosed with GB 
and PTX, although affected, could still move all their legs. However, after 48 h 
at this high dose 100% of the individuals were killed (p<0.05, Student’s t-test) 
(Fig. 6.8). 
A further bioassay using 50 ppm solutions of the tested compounds produced a 
better resolution between their toxicity. BB and GA emerged as the most toxic 
with 100% mortality (p<0.05, Student’s t-test). GB and PTX were significantly 
less potent yielding 60% and 34% mortality respectively, and significantly 
different to control treated insects (p>0.05, Student’s t-test). 
 
 
 
 
Figure 6.8 Whole insect toxicity bioassays for GA, GB, BB and PTX on N.lugens. Each 
experiment consisted of ten insects being dosed with compound. Data is mean ± SEM for 
three experiments. 
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Discussion 
 
 
6.3 Discussion 
 
I have shown that ginkgolide A, ginkgolide B and bilobalide are antagonists of 
RDL receptors with IC50 values in the sub-micromolar range. Reversal from 
inhibition is slow, requiring >20 min to wash out. This distinguishes the 
ginkgolides from picrotoxin, which washes out within 10 min. This behaviour 
of ginkgolides differs from that reported at glycine receptors, where recovery is 
observed following one minute of washout (Ivic et al., 2003). An investigation 
into the role of the 6'T and 2'A channel-lining residues using mutagenesis 
studies revealed that these residues are critical to the ginkgolide sensitivity of 
RDL receptors, suggesting that ginkgolides bind in the channel close to these 
residues. 
 
Modelling of the transmembrane domain of homomeric RDL receptors reveals 
that the 6'T and 2'A residues are amongst the channel-lining M2 residues which 
face into the channel pore. Docking of ginkgolides into the channel identified a 
hydrogen bond interaction between ginkgolides A and B and the hydroxyl 
oxygen of the 6'T residue. This binding location is supported by mutant cycle 
analysis which suggested an interaction between ginkgolides and the 6'T. This 
binding site is similar to that reported for ginkgolide binding in the glycine 
receptor pore (Hawthorne et al., 2006; Heads et al., 2008). Bilobalide also 
docked close to the 6'T but no specific interactions were observed. Docking of 
these compounds into the A2'S mutant receptor revealed hydrogen bonding 
between ginkgolides and the 2'S hydroxyl, while hydrogen bonding with the 
6'T residue was absent. T6'V mutant receptors showed no hydrogen bonding 
interactions, suggesting that this mutation disrupts binding and that this residue 
may be the principal attachment point for ginkgolides. Since the 6'T residue 
and the mutant A2'S residues have hydroxyl groups on their side chains and 
both of these residues showed H-bonding interactions in the docking 
simulations, it may be that interactions with these side chains is a determinant 
of ginkgolide binding. Indeed, the A2'S “resistance to dieldrin” mutation 
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caused ginkgolides to dock lower in the channel, in what may be a lower 
affinity binding site. Such an altered binding position may underlie the 
decreased ginkgolide sensitivity conferred by this mutation. 
 
Picrotoxin inhibits both cation-selective (nACh and 5-HT3 receptors) and 
anion-selective (GABAA, GABAC, GlyR, and GluCl receptors) receptor 
channels (Das et al., 2003; Erkkila et al., 2004; Etter et al., 1999; Schmieden et 
al., 1989; Zhang et al., 1995a). Picrotoxin is an equimolecular complex of 
picrotoxinin and picrotin (Curtis and Johnston, 1974) and picrotin is inactive in 
inhibiting GABAARs and GABACRs, indicating that the inhibitory effect of 
picrotoxin is related to the picrotoxinin component (Curtis et al., 1974; Qian et 
al., 2005). Conversely picrotoxinin and picrotin are equally potent in inhibiting 
α1 homomeric GlyR activation (Lynch et al., 1995). RDL receptors are also 
inhibited by picrotoxin (Hosie et al., 1995), however the blocking effect at 
RDL receptors is mediated solely by picrotoxinin as RDL receptors are 
resistant to picrotin (Shirai et al., 1995). This finding shows RDL receptors to 
be more GABAA-like than GlyR-like in terms of picrotoxin sensitivity. So far, 
ginkgolides have only been shown to inhibit anion selective receptors (Ivic et 
al., 2003; Huang et al., 2004; Kondratskaya et al., 2004) and more recently 
Jensen et al. (2010) described how ginkgolide X, a synthetic ginkgolide 
derivative, is selective for glycine receptors, and suggested a distinct binding 
mode for ginkgolides at anionic receptors. 
 
The ginkgolides and picrotoxin block RDL receptors with similar IC50 values 
to those at vertebrate GABAA receptors (Huang et al., 2004; Krishek et al., 
1996b). What is surprising, however, is that picrotoxin is a convulsant but the 
ginkgolides are not, and instead have neuro-protective, anxiolytic and other 
beneficial properties (Ahlemeyer and Krieglstein, 2003; Mdzinarishvili et al., 
2007; Zhu et al., 2004). The reasons for this are still unclear, but may include 
differences in bioavailability as well as differences in insect and human GABA 
receptor structure.  Other properties of these compounds include symptomatic 
relief from Alzheimer disease and a reduction in the effects of dementia 
(DeFeudis and Drieu, 2000). Furthermore, a study on human volunteers, using 
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a computer-analysed electroencephalogram, showed that Ginkgo biloba extract 
(EGb) has effects similar to those of cognitive enhancers as well as tacrine (an 
anticholinesterase), a marketed antidementia drug currently available in the 
United States (Itil et al., 1996). A more established property of Ginkgo biloba 
extract is its potent insecticidal activity. For many decades leaves from the 
Ginkgo biloba tree have been used in books to prevent insect activity, and more 
recent studies to determine potency have shown excellent activity on a range of 
insects (Sun et al., 2006; Ahn, 1997).  One potential mode of action is via 
insect GABA receptors, as many insecticidal compounds are known to exert 
their effects through these proteins. My data showing moderate potency of 
ginkgolides at RDL receptors, and perhaps more importantly, slow 
reversibility, indicates that these receptors could indeed be the insecticidal 
target of these compounds. This would be a mechanism of action that fits well 
with reported potencies (Sun et al., 2006; Ahn, 1997), with bilobalide being the 
most potent insecticide and also the most potent RDL receptor antagonist. 
Insecticides which act on GABA receptors such as hexachlorocyclohexanes, 
polychloroboranes and chlorinated cyclodienes (such as lindane, toxaphene and 
endosulfan respectively) were used widely as pesticides before their 
GABAergic mechanism of action was revealed (Casida, 1993). Fipronil is still 
one of the most common insecticides (used mainly for pest control), with 
119,000 lbs being used in California in 2006 (http://cdpr.ca.gov/). Identifying 
compounds which selectively block insect GABA receptors could facilitate 
novel insecticide design. The environmental and economic benefits of 
developing bio-organic insecticides which poses little toxicological threat to 
humans are great. Selective toxicity is the ultimate goal of the pesticide 
industry, whilst ever progressively, environmentalism is in the sights of modern 
industry. For these reasons, I deem Ginkgo biloba extracts to be an 
underexploited bio-organic alternative to current pesticide strategies. This 
study provides chemical insight into their action which will facilitate further 
development of these “green” insecticides. 
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Conclusion 
 
 
6.4 Conclusions 
 
Ginkgolide A, ginkgolide B and bilobalide are antagonists of RDL GABA 
receptors and recovery from inhibition is slow. These compounds block the 
channel of RDL receptors, binding close to the 2' and 6' residues. Interaction 
energies between ginkgolides and their binding residues are in the region of a 
single hydrogen bond and the expected interaction includes a hydrogen bond 
with the 6'T hydroxyl side chain. I hypothesise that the blocking action of 
ginkgolides at RDL receptors is the mechanism underlying their potent 
insecticidal activity. 
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Chapter 7 
 
Single-channel analysis of heteromeric 5-HT3 
receptors 
______________________________________________ 
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Introduction 
 
 
7.1 Introduction 
 
5-HT3 receptors are 5-hydroxytryptamine-gated Cys-loop receptors that are 
largely sodium selective.  Receptor activation results in a rapidly activating and 
then desensitising inward current resulting in depolarisation of the cell. Thus 
far, five 5-HT3 receptor genes have been identified (subunits A-E), and 
functional receptors containing each of these have been expressed (Davies et 
al., 1999; Niesler et al., 2003; Niesler et al., 2007). Only A subunits can form 
functional homomeric receptors, but other subunits can combine with A 
subunits to form heteromeric complexes. Isoforms of the human A-subunit 
have also been described, and recently two novel transcriptional variants of the 
B subunit (Brain-1 and Brain-2) have also been cloned (Bruss et al., 2000a; 
Bruss et al., 2000b; Tzvetkov et al., 2007). RNA for these B variants has been 
quantified using real-time RT-PCR showing that the B subunit is abundantly 
expressed in the human brain as well as in the colon and small intestine (Fig. 
7.1). Tzvetkov et al. (2007) reported that in the brain less than 1% of the 5-
HT3B subunit RNA coded for the conventional B-subunit, while the remaining 
B-subunit RNA was accounted for by approximately 75% Brain-2 and 24% 
Brain-1.  
 
Protein sequences have been predicted from the alternative transcripts, and 
compared to the canonical 5-HT3B subunit (Tzvetkov et al., 2007) (Fig. 7.1). 
The Cys-loop, four transmembrane domains (designated TM1 to TM4) and the 
HA-stretch are common to all three 5-HT3B isoforms. The HA-stretch is 
responsible for the higher conductance of 5-HT3B-containing heteromeric 
receptors (Kelley et al., 2003) (Fig. 7.2). The N-terminal localisation signal and 
the β1–β2 loop structure mediating channel gating (Reeves et al., 2005) are 
missing in the Brain-2 isoform. The six amino acids of the N-terminus of the 
Brain-1 isoform differ from the canonical form. 
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Figure 7.1 5-HT3R alternative transcripts. Above: Relative abundance of B, brain-1 (Br1) 
and brain-2 (Br2) transcripts in brain and gut. Below: Br1 and Br2 secondary structure. The 
part of the localization signal that differs between the intestinal and Brain-1 form is marked 
by hatching. Potential glycosylation sites are shown in bold. Figure taken from Tzvetkov et 
al., 2007, with copyright permission from Gene. 
 
Unpublished data from our lab suggests that Br1 and Br2 can each co-assemble 
with the A subunit, forming functional receptors in Xenopus oocytes with 
distinct agonist sensitivities and desensitisation kinetics. When A and Br1 
cRNA is injected; and when A and Br2 cRNA is injected, receptor responses 
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show distinct EC50 values (with EC50 A<ABr2<ABr1<AB) and Hill 
coefficients (nH A>ABr2>ABr1>AB), suggesting that both Br1 and Br2 
subunits can be incorporated into receptors with the A subunit.  
 
A previous study has reported that A-homomers have a conductance of 0.4 pS 
whilst A-B heteromers have a much higher conductance of 16 pS (Davies et 
al., 1999), highlighting the functional significance of the B subunit. This 
difference is due to the presence of four intracellular arginine residues, which if 
mutated in the A subunit to the B subunit equivalent residues, increases the 
conductance close to that of A-B heteromers (Davies et al., 1999) (Fig. 7.2). 
 
 
 
 
Figure 7.2 Four intracellular arginine mutations located in the M2-M3 intracellular loop 
confer high conductance to the B subunit. Taken from Davies et al., 1999 with copyright 
permission from Nature. 
 
 
Since the conductance of A homomers is too low to detect using single-channel 
electrophysiology, identifying A-B heteromers is facilitated by the fact that 
only A-B heteromers have a conductance high enough to be detected. The aim 
of this study was to determine whether Br1 and Br2 subunits form functional 
receptors in HEK293 cells and to determine the conductance of these different 
receptor channels.  
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Results 
 
 
7.2 Results 
7.2.1 Single-channel recordings 
 
Channels detected from whole-cell attached patches of HEK293 cells 
expressing human 5-HT3AB receptors opened in bursts interrupted by brief 
sojourns in the closed state. Bursts were typically 20-200 ms in duration 
although brief single openings were also observed (Fig. 7.3). Several hundred 
events were recorded and current voltage relationships were plotted using the 
mean amplitude for channels at each voltage. Conductance was calculated 
using the Nernst equation and was found to be 30 ± 1.2 pS (Fig. 7.4). 
ABr1 channels were measured using the same method. Channel events were 
similar to AB receptors with typical bursts of ~100 ms and with similar kinetic 
behaviour (i.e. brief open-closed time and burst frequency) (Fig. 7.3). 
Conductance was 33 ± 1.1 pS (Fig. 7.4). 
No channels could be detected from ABr2 transfected cells. Transfection 
parameters were varied, including varying the ratio of A to Br2 DNA, varying 
the total DNA concentration used and also using different DNA samples. 
Nonetheless, no Br2 currents could be detected. Whole-cell macroscopic 
currents of cells confirmed the expression of 5-HT3 receptors (data not shown) 
but no single-channel events could be detected. 
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Figure 7.3 Sample traces and amplitude histograms for single-channel 5-HT3 AB and 
ABr1 receptors expressed in HEK293 cells. Each histogram represents data from at least 
three patched cells. 
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Figure 7.4 Current-voltage (IV) relationships for AB and ABr1 channels expressed in 
HEK293 cells. Receptors show identical conductance. Data is mean ± SEM for at least three 
cells. Data are not significantly different (p>0.05, unpaired t-test). 
 
 
7.2.2 Flexstation analysis of heteromeric 5-HT3 receptors expressed in 
HEK293 cells 
 
HEK293 cells stably expressing 5-HT3A receptors were transfected with B, 
Br1 and Br2 receptor subunit DNA using the microporator system (DigitalBio). 
Concentration-response data were prepared for each receptor type (A, AB, 
ABr1 and ABr2) and relative fluorescence was plotted, yielding concentration-
response curves (Fig. 7.5). Data for each receptor type was collected from at 
least five separate transfections. Maximum fluorescence was decreased for 
heteromeric receptors compared to control (A homomeric) receptors (Fig. 7.5). 
EC50 values were 0.36 µM, 0.26 µM, 0.53 µM and 0.46 µM for A, AB, ABr1 
and ABr2 receptors respectively, not significantly different (p>0.05, t-test) and 
Hill coefficients were 0.49, 1, 1 and 0.9 for A, AB, ABr1 and ABr2 receptors 
respectively (Figure 7.5; Table 7.1). 
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Figure 7.5 Concentration-response curves for homomeric and heteromeric 5-HT3 
receptors expressed in HEK293 cells stably expressing 5-HT3A homomers. Above: 
Concentration-response curves. Middle: Sample traces from Flexstation (0.33 µM and 100 
µM 5-HT). Below: Maximum relative fluorescence (RFU) for 5-HT-evoked responses in 
homomeric A (control) and heteromeric AB, ABr1 and ABr2 receptors.  
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Table 7.1 Parameters derived from concentration-response curves. 
 
Subunit 
Composition 
pEC50 (µM) 
mean ± SEM 
EC50 
(µM) 
nH 
mean ± 
SEM 
RFU Max 
mean ± 
SEM 
n 
A 6.447 ± 0.17 0.36  0.5 ± 0.1  151.5 ± 9.6 15 
AB 6.580 ± 0.07  0.26 1.0 ± 0.1* 125.1 ± 6.8* 15 
ABr1 6.280 ± 0.06  0.53 1.0 ± 0.1* 110.9 ± 4.5* 15 
ABr2 6.336 ± 0.07 0.46 0.9 ± 0.1* 110.5 ± 5.1* 15 
 
nH is the Hill coefficient, n indicates number of replicates. pEC50 values are not significantly 
different. * denotes significance from A homomers (where p<0.05, unpaired t-test). 
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Discussion 
 
 
7.3 Discussion 
 
5-HT3
 receptor antagonists are currently used for the treatment of post-
operative, radiotherapy- and chemotherapy-induced nausea and vomiting as 
well as irritable bowel syndrome. It is expected that 5-HT3 antagonists will 
have wider therapeutic applications in the future, thus it is important to 
understand the consequences of subunit composition on the pharmacology and 
physiology of these receptors (Thompson and Lummis, 2007; Thompson et al., 
2007). With the higher conductance conferred by the addition of the B subunit 
and with its abundant expression levels (Tzvetkov et al., 2007), B subunits are 
critical to brain 5-HT3 signalling. Single-channel currents from AB heteromers 
were previously reported to be 16 pS (Davies et al., 1999; Kelley et al., 2003). 
My findings here of 30 pS are higher than these finding and may be due to 
different experimental conditions. More importantly, however, ABr1 channels 
showed similar behaviour and identical conductance to AB channels, 
confirming that they can be expressed in HEK293 cells and form functional 
channels with similar properties to AB receptors. This is an important finding, 
confirming the functionality of this abundantly expressed brain 5-HT3 subunit.  
 
Since the Br2 is missing such a large amount of sequence, it is unsurprising 
that functional channels were not observed with single-channel 
electrophysiology. This finding would suggest that either Br2 subunits can be 
expressed in oocytes but not HEK293 cells or that our previous findings are in 
fact an experimental artefact. Attempts to further validate these findings using 
the Flexstation yielded ambiguous results. The EC50 value arrived at for A 
homomers (0.36 µM) is close to a previously published value of 0.2 µM (Price 
and Lummis, 2005), where the same fluorometric assay was used. Other studies 
using electrophysiological methods have published EC50 values of 2.1 µM and 
1.4 µM for the same receptors expressed in HEK293 cells and Xenopus oocytes 
respectively (Reeves et al., 2001; Spier et al., 2000). Whilst there was found to 
be no change in EC50 for stable A cells transfected with the different B 
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subunits, there was a significant increase in Hill coefficient and a decrease in 
the maximum response (RFU-Max). This is in contrast to that reported when 
these receptors are expressed in Xenopus oocytes where the opposite is 
observed - a decrease in Hill coefficient from 2.2 to 1.1 when the B subunit is 
incorporated into receptors (Lochner and Lummis, 2010). Additionally, since 
the B subunit has a higher conductance than the A subunit (Kelley et al., 2003), 
an increase in RFU-Max may be expected for heteromeric receptors, although 
we cannot be sure if this is the case. Therefore this observed decrease in RFU-
Max may be either an experimental artefact or a consequence of decreased 
open probability in heteromeric channels. Of course, transfections may not 
have been successful, but the significantly different Hill coefficients would 
suggest otherwise. As our preliminary work on Br2 receptors (in oocytes) 
yielded an A-like concentration-response profile (i.e. similar Hill coefficient 
and EC50), it seems likely that this is indeed an experimental artefact and that 
the Br2 subunit does not form functional channels. Furthermore, since this 
subunit is missing extracellular loops D and A as well as the β1-β2 loop, which 
is essential for gating (Reeves et al., 2005), it is unlikely to be involved in the 
formation of a functional 5-HT binding site. Despite this finding, the high 
abundance of Br2 transcripts detected in the brain warrant further investigation 
of the role of Br2. Perhaps this transcript plays an intracellular role in 
regulating receptor transcription and/or surface expression. Such an 
explanation could account for our previous results in oocytes, where a change 
in EC50 was observed for ABr2 receptors. Br2 cRNA may have altered the 
formation and/or regulation of homomeric A receptors. On the other hand, 
expressed Br2 subunits may have been incorporated into receptors with a 
stoichiometry too low to increase channel conductance (perhaps one Br2 
subunit per receptor), but enough to affect the concentration-response profile. 
Further studies could determine if Br2 subunits reach the cell surface using 
immuno-staining or with conjugated fluorescent tags. 
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Conclusion 
 
 
7.4 Conclusions 
 
The 5-HT3 Br1 subunit can form functional heteromeric channels with the A 
subunit and these heteromeric channels have a conductance of 30 pS, identical 
to AB receptors. The Br1 subunit is therefore an important component in brain 
5-HT3 signalling. The Br2 subunit does not form functional channels with the 
A subunit in HEK293 cells and is unlikely to form functional 5-HT3 receptors. 
However, the high abundance of the Br2 transcript suggests that it may play an 
intracellular role in receptor regulation and/or surface expression and further 
experiments on Br2 should focus on these aspects. 
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Chapter 8 
 
Future directions and final remarks 
______________________________________________ 
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Future directions  
 
 
The aim of this thesis was to investigate the structure and function of Cys-loop 
receptors and to generate a greater understanding of these receptors in general. 
I began by assessing the biophysical properties of RDL receptors. I followed on 
from this by assessing the efficacy of a range of agonists on RDL receptors, 
thereby identifying the critical determinants of agonist binding. Following on 
from this work, I identified several residues in loops B, C and D that are 
involved in ligand binding. I have also identified the binding location of 
ginkgolides and bilobalide in the channel pore. Finally, during a visit to Cecilia 
Bouzat’s lab in Bahía Blanca, Argentina, I made single-channel recordings of 
heteromeric 5-HT3 receptors, confirming the functionality of brain variant 
subunit Br1. 
 
The work on biophysical properties of RDL receptors has confirmed that these 
receptors express quickly (within 24 h) in Xenopus oocytes and that they are 
chloride selective channels. Further work on this property could include 
mutagenesis of the -1' residue (alanine) to a glutamate - the equivalent residue 
in the cation-selective nAChR and 5-HT3R - to determine if the ion selectivity 
filter is in the same location in RDL receptors.  
RDL receptors showed resistance to changes in pH. This insensitivity to 
changes in pH distinguishes these receptors from their vertebrate orthologues, 
the GABAA receptors, and this difference may be due to the absence of charged 
residues involved in receptor gating. Future work could involve mutagenesis of 
charged residues in the pre-M1 and β1-β2 loop regions, since these regions 
contain many key gating residues (Bartos et al., 2009a). This may lead to a 
greater general understanding of pH sensitivity in Cys-loop receptors. 
 
In Chapter 4 I identified the critical features of agonists that bind to and 
activate RDL receptors; a charged amine and an anionic centre are required for 
agonists to bind. Additionally, there is a size requirement for agonists, with the 
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most potent agonists being ~5 Å in length. This work provides a set of structure 
activity relationship (SAR) data which could be used to generate potential 
antagonists. Further work could include the generation of a large set of GABA 
analogues, which may lead to the identification of an RDL specific antagonist. 
This may be useful for insecticide development as well as a tool for further 
studies in invertebrate neuroscience.  
 
In Chapter 5 I identified several residues that are involved in ligand binding in 
RDL receptors. Loop B residues E204 and F206 and loop C residue Y254 seem 
the most likely candidates for interactions with the ammonium end of GABA. 
Loop D residues R111 and Y109 seem the most likely candidates for 
interactions with the carboxylate of GABA. Homology modelling and docking 
experiments support these binding interactions. Further studies could involve 
unnatural amino acid mutagenesis of these residues: fluorination of aromatic 
residues would determine whether there is a role for π electron density on the 
face of aromatic rings in ligand binding. Charged residues should be substituted 
with unnatural amino acids with similar side chains structure but with varying 
charge. These studies would clarify beyond doubt the role of these candidate 
‘binding’ residues. 
 
In Chapter 6 I identified Ginkgo biloba extracts, ginkgolides and bilobalide, as 
antagonists of RDL receptors with IC50 values similar to picrotoxin. 
Ginkgolides wash out more slowly than picrotoxin, making these compounds 
more potent blockers of RDL channels. Mutagenesis, modelling and mutant 
cycle analysis identified the 2' and 6' M2 channel-lining residues as being part 
of the ginkgolide binding site. Whole insect bioassays confirmed the 
insecticidal potency of these compounds, leading to the hypothesis that these 
compounds exert their insecticidal properties through RDL-like receptors. 
Further work could involve screening these compounds on a range of insect 
species, identifying susceptible and resistant species. Resistant species should 
be genetically catalogued with special attention to Cys-loop receptor structure, 
and particularly, the M2 2' and 6' residues. 
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In Chapter 7 I confirmed that the brain 5-HT3R B subunit variant Br1 co-
expresses with the A subunit, forming functional heteromeric receptor channels 
with a conductance similar to heteromeric AB receptors. Br2 containing 
channels however could not be detected in this study, leading to the hypothesis 
that this transcript (Br2) may play a role in other cellular processes such as 
receptor trafficking and/or regulation of expression. It is also quite possible that 
this transcript is not translated at all. Further studies on these subunits could 
involve mutagenesis studies and molecular modelling, as has led to the further 
understanding of the arrangement of A and B subunits in heteromeric 5-HT3 
receptors (Lochner and Lummis, 2010). Immunocytochemistry studies, using 
antibodies or fluorescent tags, could complement such work to determine 
whether Br2 subunits reach the cell surface. 
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Final remarks  
 
 
In this thesis I have identified the critical determinants of RDL receptor 
function: pH sensitivity, ionic selectivity, agonist requirements and binding site 
residues. I have also identified natural compounds (ginkgolides) which block 
RDL receptors and which are potent insecticides. Together these findings 
provide potential for the development of RDL-targeting insecticides as well as 
pharmacological probes which may be useful in further studies on insect 
GABA receptors. I have also confirmed that 5-HT3 receptor brain subunit Br1 
forms functional receptor channels. Overall this work has lead to a greater 
understanding of Cys-loop receptor function and the findings presented here 
may benefit further biomedical and neuroscience research.  
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